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1. Introduction
A considerable amount of R&D&I has been carried out in recent years in the area of teleme‐
dicine and e-Health directed at supporting innovative health care models for people with
chronic health conditions such as hypertension, cardiac insufficiency, chronic pulmonary
obstruction, asthma, diabetes, cancer, dementia and other ailments [1]. The objective is to
implement more appropriate and effective health care models in order to maintain health
under everyday conditions, avoiding serious complications and without the need to resort to
emergency services and hospital admittances. One priority is to avoid or delay for as long as
possible the situation of dependence on the health care system for pluripathological conditions.
The development of telehealth applications is guided by its potential to confront the challenges
brought about by the aging of the population and financial restrictions together with the need
to satisfy the population for better services and access to them.
In this context, a convergence can be observed between the transformation movement of health
care systems, the development of new information and communication technologies (Internet,
Web 2.0, 3G and 4G mobile communications, touch-screen terminals, etc.) which have a high
support potential for new ideas in the field of health care implying the active support of the
patients and facilitating collaboration environments between all of the actors involved.
It must be borne in mind that telehealth systems and services are in the definition and
positioning phase in traditional health care systems and coexist with other systems such as
Telecare, Personal Health Systems (PHS), mobile Health (mHealth) and Personal Health
Applications (PHAs) with which often overlap [2,3].
© 2013 Monteagudo et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
It is important to consider that innovation in telehealth does not only rest in technological
advances. The system of innovation in this domain is very complex and interdependent. A
fusion of technology with health care knowledge and the organization of health care systems
is necessary together with measures to empower the users and a redefinition of the contact of
the professionals with the patients.
In this chapter, an experience is described in the conception, design, implementation and
evaluation of a Platform of Innovation in Telehealth Systems (PITES) oriented at improving
the health care of chronic, fragile and dependent patients.
The PITES platform is a stable and public innovation infrastructure. It is made up of a
technological platform, services and tools, with its use directed at research groups, public or
private entities and organizations, with the objective of offering support for the obtaining of
evidence on new models for health care provision based on ICT (Telehealth) in scenarios
related to chronic illness and dependency.
PITES is directed at broaching two main objectives: a) facilitating and accelerating the
development of telehealth applications by making available technological infrastructures
which in another way would not be tackled or would have to be designed and constructed
from scratch by each project, and b) promote interoperability through the adoption of open
standards for the communication of medical data and information (semantic interoperability).
PITES stems from experience and lessons learned over 15 years in the design, implementation
and use of telehealth applications in different environments and contexts of real application,
supported by a large number of pilot projects and trials. PITES currently serves as an infra‐
structure for diverse projects in different locations in Spain. PITES also forms part of the Accion
B3 of the European Innovation Partnership for Active and Healthy Ageing [4].
The PITES platform supports research or innovation projects, not health care activities nor
commercial services. The platform permits different telehealth projects to be implemented in
a flexible and transparent manner using different local approximations and contexts of use for
both professionals and patients. PITES incorporates the philosophy of separating the applica‐
tions of the infrastructures that support them.
As an R&D&I platform it has been conceived to be flexible, functionally transparent, secure
and with the capacity to evolve and coexist with other platforms (for research or clinical use)
by means of technical and semantic operability mechanisms based on standards. Technolog‐
ically, it is aligned with the current convergence framework for the provision of digital services
on IP networks using Web technologies and SOA.
PITES follows an open innovation model promoted from the knowledge of the professional
health users for the application of secure, accessible and interoperable telehealth environments
using open standards. The PITES digital ecosystem gives each Project the freedom to design
and implement its protocols.
The structure of the chapter is as follows: The two goals of the PITES innovation activi‐
ties are described in section 2. The obtaining of evidence (section 2.1) and the interoperabil‐
ity of the clinical information (section 2.2). As regards the obtaining of evidence, we begin
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by  presenting  the  current  context  of  the  evaluation  in  e-services  (section  2.1.1)  and
methodological basis which has shown to be more suitable for the obtaining of evidence
(section 2.1.2). The challenges that persist are highlighted, brought about by the intrinsic
complexity of the environments in which the evaluations have to be carried out. The need
for implementation in the organizations stands out as the factor that most compromises
the  viability  and validity  of  the  process  (section  2.1.3).  The  methodology  designed and
proposed in PITES is  then described in order to tackle the complexity of  the search for
evidence on the e-services process (section 2.1.4). As regards interoperability, the fundamen‐
tal aspects of interoperability in clinical information (section 2.2.1) and the interoperabili‐
ty framework of the platform (section 2.2.2)
The PITES platform is presented in section 3. Firstly, a conceptual model of the organizational
and functional framework is described as a proposal for the reduction in users, resources and
its interactions to which the interventions must be adapted to be able to be evaluated with the
support of the platform (section 3.1). After that, the architecture of the PITES platform is
presented as an open system of distributed services and its advantages in collaborative
research and innovation in this field (section 3.2). Finally, some of the services that currently
support the platform and which already act as permanent components supporting the projects
are described (section 3.3).
In section 4, as a result of the platform, a description of some of the already finished projects
is included together with very brief descriptions of some of the current projects that our unit
is working on plus a list of current projects of other research groups.
2. Context of innovation within the PITES scenario
2.1. Evaluation of services based on telemedicine
2.1.1. Current context of the evaluation of e-services
One of the permanent challenges facing e-health, and therefore telemedicine and its effects is
the obtaining of scientific, generalized and reliable evidence (transferable between different
contexts) on it. There are numerous reasons for evaluation: promotional, pragmatic, ethical,
medical-legal, even academic. The objective is to promote and legitimize practices of excel‐
lence, evaluate the policies, regulations and national legislations on e-health and value its
impact in terms of efficiency and technical and clinical effectiveness, impact on the organiza‐
tion, health staff, costs, patient satisfaction and personal ethical health aspects, confidentiality
and safety.
The recommendation for evaluation has been endorsed from multiple authorities and inter‐
national organizations such as the World Health Organization in its “eHealth Program for
Health-Care Delivery” (eHCD) [5] and the “Global Observatory for eHealth” [6], which
established that services based on e-health will be essential when they demonstrate that they
are based on evidence, requiring well-defined agreed specifications and criteria for it, and
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validated by means of controlled experimental trials or by consensus widely accepted by
experts. Also within the ambit of the European Union, by means of eEurope initiatives [7] or
i2010 [8], the need to strengthen the aspects of demonstration and evaluation in projects has
been made clear to allow the complete analysis of the results to be undertaken and make
available the evidence of quality for the drawing up and dissemination of directives on good
practices.
Traditionally, the evaluation of e-health services has brought to light significant difficulties
giving rise to uncertainties and thus resistance to its implementation by consultants and
managers. The belief that the implementation of formal evaluation processes constitutes an
obstacle for developers and the commercial and economic context is currently being dismissed.
It has come to light through demonstration that the systems are effective, cost-effective safe,
robust, accessible, and usable, as well as a source of benefits and knowledge, an aspect which
is known in the technological sector as “evidence-based business” [9]. Nevertheless, it is
evident that the organizations and health systems determine a priori numerous factors that,
in evaluation interventions, condition the work frameworks and their implementation, and
therefore the potential final results. In this sense, there still remain significant methodological
challenges and practical implementations mainly related to two aspects: 1) the interdiscipli‐
nary nature of the field of e-health, and 2) the intrinsic complexity of the context in which the
evaluations have to be carried out.
As regards the first aspect, it is an obvious fact that e-health constitutes a heterogeneous and
interdisciplinary field of science with which two areas of research converge fundamentally (in
turn, trans-disciplinary): the computer aspects of health (technological ambit) and research
into health services (socio-health ambit). Traditionally, all of them use different languages,
cultures, reasons and operating conditions which have generated divergent working templates
[10]. These silos of parallel competencies are a cause of additional difficulties in the develop‐
ment of e-health. In the past decades efforts have been directed at achieving a mutual recog‐
nition between the respective disciplines and a search for synergies and single paradigms [11].
The second aspect refers to the intrinsic complexity of the context in which the evaluations
have to be carried out. During the past two decades, the results achieved related to the
dissemination of the innovation, knowledge and experience in the ambit of health have not all
been as satisfactory as was hoped. The cause would have to be sought in some of the work
strategies more orientated towards the resolution of complicated problems rather than a
complex problem [12]. Starting from this idea, different authors have carried out an approxi‐
mation of the organizations and health practice from the perspective of complexity theory,
contemplating them as adaptive complex systems [13, 14, 15, 16, 17]. Parallelisms related to
questions such as changing behaviors, interrelated, yet not totally predicable, whose evolution
and behavior patterns respond to the relationships between their components on the basis of
non-explicit rules, the appearance of emerging behaviors, “attractor patterns”, effects of self-
organization, the influence of “shadow systems”, etc. have come to light. By means of the
aforementioned work, it has become possible to explain different aspects of behavior dynamics
in relation to clinical care, education, leadership and management in health environments,
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which have opened up new ways and action strategies related to evaluation, as well as
improving the quality and adoption of innovations.
2.1.2. Complex interventions and hybrid evaluation methodologies
In the health environment, an intervention is a deliberate action through which it is hoped to
bring about an effect or change in any aspect of health which is the object of the aforementioned
action. The intervention may be directed at individuals, collectives or at a population level;
and the purpose may be a pathology, a behavior, etc. The concept of a “complex intervention”
[17] arises from the evolution of the interventions that are extended or influenced by or
immersed in organizational aspects, processes, and technological adoption. From the perspec‐
tive of complexity theory, a “complex intervention” is an intervention in which components
that act independently and interdependently become involved, and are characterized by the
difficulty in determining which participating agents are active elements in the intervention
and how some are related to others and with the rest of the agents, and this represents a
challenge as regards the definition, development, documentation, reproduction and evalua‐
tion of the intervention.
It is evident that any intervention based on e-health services constitutes in itself a “complex
intervention” [18]. Research into interventions has been a natural field of development of
research into health services and its objective has been to gain knowledge into the impact of
these interventions at a population level. Traditionally within the ambit of health, the clinical-
epidemiology evaluation methodology most widely recognized and accepted as the “gold
standard” in order to obtain evidence of the maximum quality is the Randomized Controlled
Trial (RCT) [19]. By means of an RCT the validity and effectiveness of an intervention is
determined quantitatively as are the possibilities of the transfer or generalization of the results
obtained.
Historically, RCTs have been used in the evaluation of interventions in the context of acute
illnesses, consequently, in short-term interventions and acute care hospital environments. It is
a well-described fact that when this evaluation methodology is adopted in other context that
imply periods of mid- to long-term intervention, such as, for example in the case of chronic
illnesses, or complex environments such as e-health interventions (complex interventions),
intrinsic practical limitations emerge [20]. These limitations have to be taken into account not
only in the design of the studies and the evaluation of the results, but also the planning of the
intervention itself [21], which has to adopt centered services design on the user [10], which
also take into consideration the organization in which the new services are going to be
implemented together with social aspects [22] and even the implementation process itself [23].
As a response to these challenges, and inspired in some cases in the industrial processes [24],
the evaluation strategies that are shown to be potentially more efficient in the evaluation of e-
health services are those which combine longitudinal synergy [25], itinerary [26], progressive‐
ness [27], dissemination of the innovation [28], and a simultaneous consideration of the
organizational aspects and human behavior from the perspective of complexity and complex
adaptive systems [29]. Following these directives, “hybrid” evaluation models have been
proposed that, setting out from an eclectic point of view, combine the characteristics of the
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traditional evaluation models (such as RCT) and the different perspectives of each of the
“stakeholders” related to the process [10, 30-33].
The “hybrid models” have the capacity to tackle the evaluation as a successive process, in
stages, to obtain the evidence in different ambits, by distinguishing at each phase which
collectives have to be undoubtedly satisfied with the new resource, and for which ones is
achieving the optimum result optional [25]. This division of the evaluation into consecutive
stages or phases (see Figure 1) is a response to the complexity that is dealt with as a generation
process and successive accumulation of knowledge of the interventions making each phase
correspond to a different ambit of evidence. In general three generic phases are established:
the first one related to the evaluation of the concept and the prototype of the service, the second
one related to the evaluation of the results relative to the impact of the service in innovation
in processes and health results in controlled environments, and a third pragmatic evaluation
phase related to the long-term impact in production environments.
Figure 1. Generic structure of the hybrid models.
The progress of the evaluation is materialized by generating useful information, appropriate
for each phase, and in this way reducing the profile of uncertainty or ambiguity in successive
phases. It is, in short, a question of a gradual increase in knowledge on the intervention by
predicting valuable information in advance which allows the risk to be reduced in successive
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phases. In this context, the risk is related to the resources invested in the evaluation: economic,
infrastructures, human, etc. These progressive evaluation models establish decision-making
elements between successive stages (“stakeholders”) who, on the one hand, are recipients of
the evaluation results of the previous phase. On the other hand, between its functions, it may
be that which decides whether the evaluation progresses or not to the following phase, or if it
is necessary to activate an iterative cycle with the objective of modifying some aspects of the
service and restart or resume the evaluation at a determined stage or point.
In these methodologies an interdisciplinary vision of the process is combined assuming the
diversity and complexity of the environment by means of aspects such as: 1) dealing with the
evaluation process in successive phases by contemplating an ambit of differentiated evidence
at each stage, 2) consider at each stage that the “stakeholders” are more suitable for deciding
the continuation, closure or repetition (health and non-health professionals, patients, carers/
caretakers, evaluation agencies, health authorities, the research group) and 3) make it possible
to gain progressive knowledge on the intervention which at the same time acts as a risk control
mechanism which establishes a road map for the actors and agents involved, offering a clear
idea of where the project is and what is required at each stage.
The proposal for “hybrid methodologies” assumes a significant advance in the evaluation of
“complex e-health interventions” in the health context, conciliating holistic focuses with
widely-accepted traditional validation procedures such as RCT. However, to date, the hybrid
methodologies constitute general and not very specific proposals. In spite of setting out clear
objectives in each of its phases, they are clearly non-specific in some relevant aspects lending
it a generic character and therefore a non-direct application. The difficulties are aggravated
even more by taking into account that the context in which the evaluations have to be carried
out, there are some health systems unprepared for it, highlighting in the majority of cases, a
lack of support and recourses necessariy to make the implementation of the interventions more
visible when carrying out the evaluation.
2.1.3. Implementation as an element of complexity in the evaluation
“Implementation” is understood as the full assimilation of a service by organizations for its
routine use and sustained from the permanent recourses and infrastructures. The implemen‐
tation of e-health services, and in a wide sense the ICTs as a support to health attention, is in
itself a complex process that has to be managed [34, 35], and which implies numerous
determining factors in different ambits: organizational, technological, work and work flows
and the individuals themselves. The implementation of e-services assumes the insertion of
technology, reengineering of assistance processes, redistribution of resources, modification or
addition of new roles, articulation of processes and collaboration models between different
assistance levels, etc. Currently, the implementation of e-health services is still too slow and it
is a fact that the said process is unsuccessful on a large number of occasions [36]: the lack of
suitable infrastructures, the impossibility of finding financing, complications with the scala‐
bility and uncertainty of efficiency and sustainability.
In this sense the strategy of disseminating innovation and the management of change is
relevant in organizations such as the “Breakthrough Series Learning Model” [28, 37], “Con‐
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tinuous Quality Improvement Model” [38], “Performance Improvement Model” [39], “De‐
ming Model” [26], among others. Equally the combination and putting into practice of “top-
down” and “bottom-up” strategies with solid institutional support (political and
organizational), leadership and participation of health and non-health professionals, the
specification of clear programs for change and the maintenance of permanent “feedback” from
all of the stakeholders.
There is the opinion in which it is necessary to deal with implementation strategies that
accompany design and development, in such a way that the new e-services are compatible
with the infrastructures, purposes and local demands, and that the organization and the main
“stakeholders” are involved in the local context and extended by adopting wide-ranging
focuses so that the solutions are not extremely localized [35].
It seems evident then that implementation is probably the process that contributes the greatest
complexity to the insertion of new e-services into the organizations, and therefore has a
significant impact on the strategies for the search for evidence and evaluation on the said e-
services. Nevertheless, the implementation forms part of the longitudinal evaluation process
and therefore cannot be left out; the evaluation process cannot conclude until the e-service has
been totally implemented into the organization and has had a mutual integration with the
work flows, since there are extremes that cannot be determined without an adaptation being
reached at a local context.
However, assuming the need to carry out an early implementation of the e-service into the
health organization in order to be evaluated, it would have implications that might compro‐
mise the internal and external validity of the said evaluations, and even the feasibility itself of
carrying it out. Among others, the most relevant implications are:
• To deal “suddenly” with the complexity of the implementation process
• Carry out local adaptations of the intervention, which could compromise the capacity for
the generalization of the results obtained and therefore its transfer capacity
• Extend the envisaged period of time prior to the beginning of the evaluation, a fact that
might compromise the committed administrative periods, especially in the context of
research projects
• Make public the high risk of not achieving homogeneous deployments in interventions
which, in order to achieve a sufficient volume of users, require multicentre scenarios
Therefore, it is relevant to develop proposals on how to make the need for the implementation
and evaluation of an e-service in an organization compatible. In other words, within the
framework of the “hybrid methodologies”, search for evidence on an e-service at the same
time by controlling the complexity that the implementation process introduces [40].
In this sense the following questions are posed: Is it possible to delay or at least contain within
some essential minimums the implementation of the intervention in the health organization
until the final stages of the evaluation? What type of resources or infrastructures is it necessary
to authorize to make the deployment of these conditions viable? And under these conditions:
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What type of evidence on the intervention can be reached? Finally, what are the advantages
of achieving a certain level of evidence on the intervention during the early stages of the
evaluation?
The adoption of a strategy of “minimum implementation” during the initial phases of the
evaluation offers the following advantages:
• It makes an initial distancing of the conditions of the local outline possible, facilitating the
work of identifying the functional components of the intervention and in this way obtain
greater general or transferable transparency evidence.
• Increase the possibility of success in multicentre interventions since a greater homogeneity
in the interventions can be achieved without compromising either its internal or external
validity.
• It reduces institutional resistance due to the lesser commitment to initial resources.
• It implies the professionals (health and non-health) before getting to full implementations,
thus facilitating the “top-down”, “bottom-up” and “peer-to-peer” dynamic during the
process
• It increases the confidence of the promoters and “stakeholders” to continue the evaluation
of the intervention on making it possible to obtain early evidence. If the evidence obtained
is negative, it permits: 1) to have the possibility and margin of maneuver to carry out rethinks
of the intervention that will still be viable; 2) if it were inevitable, interrupt the progress of
the evaluation of the intervention having been committed to up to the moment of minimum
resources.
Finally, the following considerations have to be taken into account:
• The putting into practice of a strategy of “minimum implementation” in the initial phases
of the evaluation requires the resources and infrastructures required to make the deploy‐
ment of the intervention viable to be contributed to the organization externally for the
aforementioned period of time. Under ideal conditions, it would only need the participation
of the health and non-health professionals and as an organizational resource, facilitating
externally all of the support necessary for the deployment of the experimental studies as
part of the methodological support
• A “minimum implementation” during the initial phases does not shorten the total evalua‐
tion period since the process does not conclude until a complete adaptation of the inter‐
vention at the local context is achieved. However, it does make the progressive obtaining
of evidence on the intervention possible by maintaining of the resources committed in the
initial phases since they are those that contribute the greatest uncertainty and risk and
therefore those that have to be the most protected from the effects of additional complexity
that contribute a more wide-ranging implementation process.
The PITES platform responds to the aspects below:
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• It proposes an evaluation strategy in interventions based on e-health based on the hybrid
models that make the obtaining of evidence possible in the early stages implying some
minimal institutional resources (“minimum implementation”) in such a way that knowl‐
edge may be obtained, and at the same time, contain the complexity of the implementation
process (section 2.1.4)
• It contributes a technological platform that, based on a generic conceptual model, makes
possible the deployment of interventions become evaluated under conditions of “minimum
implementation” during the initial phases, externally facilitating the resources and infra‐
structures necessary to the organizations, in such a way that for the health professionals,
patients or other participating users, the intervention is perceived as an assistance service
integrated into the health context (section 3)
2.1.4. Evaluation methodology of e-services in PITES
Within the framework of the PITES platform the specification of an evaluation methodology
has been carried out aligned with the hybrid methodologies for the search for evidence into
the new assistance services based on telemedicine directed at chronic illness.
The PITES evaluation methodology is made up of four consecutive pages (Figure 2): pilot
phase, exploratory trial phase, clinical trial phase, and the implementation phase. Responding
to the classic sequence in hybrid models, an initial stage related to the evaluation of the concept
and the configuration of the intervention prototype (pilot phase), followed by an intermediate
step related to the evaluation of the results relative to the impact of the intervention in the
innovation in health processes and results (exploratory trial and clinical trial phases), and a
third pragmatic evaluation stage related to the long-term impact of the intervention in
production environments (implementation phase).
By means of the support of infrastructures and resources that the PITES platform contributes,
it is possible to carry out phases 1 to 3 (pilot, exploratory trial and clinical trial) under conditions
of “minimum implementation”.
The description of the phases is as follows:
Pilot phase
The objective of this phase is the evaluation of the technological prototype that is going to
support the intervention as regards the quality and functioning of the prototype, usabili‐
ty,  and  satisfaction  of  the  users  of  the  prototype.  Internally  the  process  involves  two
consecutive tasks. Firstly, the design and development of the technological prototype under
optimal laboratory conditions. This first task has the character of a concept trial, explorato‐
ry and iterative until the optimum prototype is configured. For this, it is necessary to carry
out a study on the state of  the art,  available technologies,  medical  devices,  communica‐
tions, etc. In second place, the carrying out of a feasibility study under controlled practi‐
cal conditions outside the laboratory. Few participants are required to carry out this initial
field trial (It would be valid for the proposal of the basic model to not exceed 20 patients
nor more than 5 health professionals), as is the availability of equipment under optimum
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working conditions, together with well-trained and motivated users. It is not a question of
carrying out a comparison study since the focus continues to be on the technological system
and its  optimization;  therefore throughout the development of  this  phase,  proposals  for
improving the prototype are gathered and then sent to the laboratory. The technological
prototype is developed externally to the health organization with the participation of health
professionals among which include those belonging to the research group and the resources
and  infrastructures  required  are  facilitated  externally  to  the  health  organization  by  the
PITES platform.
To pass from phase 1 to phase 2 a positive evaluation of the results of phase 1 is necessary in
relation to: the test of the concept, the technical viability, the acceptability of the health
professionals, and the satisfaction of the users of the system. The decision is brought about
within the ambit of the research group itself and is made effective by the promoting or
financing entity.
Exploratory trial phase
Once the technological prototype has been optimized, it is time to begin the evaluation of the
intervention in the health aspect of clinical efficiency. For this and, in agreement with the
requirement to maintain a controlled complexity by means of a “minimum implementation”
in the health organization, it is necessary to establish the provision model by means of carrying
out the intervention emphasizing the resources and infrastructures required that are going to
be facilitated externally to the health organization by the PITES platform. To carry out this task
the proposed procedure is the carrying out of one or more exploratory trials whose objective
Figure 2. The PITES evaluation methodology.
PITES: Telemedicine and e-Health Innovation Platform
http://dx.doi.org/10.5772/57021
173
is to experiment with the intervention, varying the deferent components and alternatives, to
observe the effect of the intervention in its entirety and its consistency in different contexts,
viability, participant acceptability, etc. As a result, evidence has to be obtained on the most
suitable parameterization of the clinical trial (the following phase), to specify the intervention
and the optimum studies.
Aspects such as identifying the key processes and results of the intervention, identifying the
mechanisms through which the intervention would lead to an improvement in the results, the
identification of the application difficulties or implementation of the intervention, the estab‐
lishment of the collectives or groups on those that influence the intervention by optimizing its
probability of response, the determination of the components and the intensity of the inter‐
vention in accordance with the available possibilities and resources, or the evaluation of the
learning curve of the skills of the users are basic aspects to be determined in order to be able
to guarantee the performance in the suitable intervention in the clinical trial phase. It is also
not necessary to perform an analysis and modeling of the intervention that is required to be
evaluated. If it is going to be compared with a practical standard, or an improved practice (for
example, the same intervention with and without the support of telemedicine), it will also be
necessary to model the comparison intervention which might be the same or even more
complex. As well as the modeling process, if it is possible, it may be very interesting to carry
out a simulation of the intervention by means of experimenting functional aspects of the
scenario, the modeling of components, the statistical and mathematical model, etc.
As regards the methodology of the exploratory trial phase, the same degree of quality of
evidence is not demanded as in a controlled randomized clinical trial; while it is inacceptable
methodologically to modify an intervention during the course of the controlled randomized
clinical trial, a study in this phase may be developed precisely to carry out trials on the
variations in the intervention and clarify which are the most appropriate with views to the
clinical trial. The criterion is to carry out one or more studies with a more adaptable develop‐
ment especially as regards the rigidity of the protocols and the inclusion of patients. The
carrying out of quasi-experimental studies with sample sizes that do not exceed 100 patients
and 10 health professionals may be suitable in this phase.
The availability of “Living Labs” as a community experimentation context may result in an
appropriate option as it would carry out formal studies in social environments with a con‐
trolled complexity. If this is not possible, it would be advisable to carry out an analysis on the
context in which the intervention is going to be evaluated since the degrees of complexity
which show the different health problems are diverse and dependent on the context. It is
recommended to consider aspects related to: the illness itself (risk factors, co-morbidity,
prevalence, etc.), the patient (lifestyle, adherence to the treatment, symptoms, etc.), and the
social context (social support, socio-economic level, cultural level, etc.).
The support of the exploratory trial and the corresponding interventions (resources, logistics,
and infrastructures), is carried out externally of the health organizations involved and counting
exclusively on the participation of health professionals belonging to the said organizations and
contributing the resources and infrastructures required by the PITES platform.
Telemedicine174
To pass from phase 2 to phase 3 a positive evaluation of the results of the experimental studies
carried out in phase 2 is needed which guarantees the viability of carrying out the controlled
randomized clinical trial in order to evaluate the intervention in terms of efficiency. The
decision is made within the ambit of the research group itself and put into effect by the
promoting or financing entity.
Clinical trial phase
This phase is key to the evaluation of the efficiency of the complex interventions and consists
of carrying out a controlled randomized trial with all of the rigor and power required,
assuming the standard design aspects that require these types of trial: inclusion and exclusion
criteria, sample size, criteria and duration of the intervention, randomization and informed
consent of the participants, etc. From the knowledge accumulated in phase 2, definitive
decisions must be taken on the nature of the intervention in order to standardize the inter‐
vention going to be evaluated and minimize the biases that limit not only the internal but also
the external validity.
During this phase, unlike the previous ones, it is absolutely prohibited to make modifications
in the protocol of the intervention. The minimum sample size determines the statistical power
of the clinical trial and there must be the possibility of carrying out a replication of the
intervention in multiple centers (multicentre trial), maintain its uniformity of implementation
to guarantee the internal and external validity of the study and the generalization of the results.
The participation of multiple centers contributes an additional value as it makes possible the
study in different contexts of established patterns and emerging self-organization behaviors
shown by the health professionals that are of doubtable use in phase 4.
The support of the clinical trial and the corresponding interventions (resources, logistics, and
infrastructures), are carried out externally to the health organizations involved and counting
exclusively on the participation of health professionals belonging to the said organizations and
contributing the resources and infrastructures required by the PITES platform. It is essential
that the resources and infrastructures external to the health organization do not represent a
direct object of evaluation in the clinical trial, and act exclusively as a support to the operational
deployment of the intervention.
To pass from phase 3 to phase 4 a positive evaluation of the efficiency of the intervention in
the results of the trial, together with a decision from the health authority to adopt, is necessary
(for example, an autonomous health service) with the support or endorsement of a Health
Technology Evaluation Agency. Therefore, the ambit of the decision is outside the scope of the
research group, although its continuity and participation in phase 4 may still be relevant.
Implementation phase
Once the evidence on the efficiency of the health of the intervention is demanded, it is necessary
to adapt it to the local contexts in order to deal with two objectives: the full implementation of
the intervention in the health organization in its technologic and health ambits, in such a way
that it constitutes a health procedure more as regards the provision of all of the resources and
infrastructures required at the margin of the external supports, and from that, the carrying out
of financial cost studies and long-term studies to determine the efficiency of the intervention.
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For this, it is necessary to count on a significant and essential institutional support that
promotes and manages the change and the dissemination of the innovation to the health
organizations participating in this phase, and preferably from legal and financial instruments
that regulate the introduction of new technologies in the National Health System as a factor
essential for the progression of the intervention as a routine health procedure.
The total effect of knowledge that would contribute to carrying out the local implementation
in different socio-health contexts from the participation of several organizations, would
contribute to the convergence of the intervention towards the standardized health procedure.
Taking the methods and other knowledge accumulated during the development of phases 2
and 3 as reference, it is necessary to carry out an analysis on the operative feasibility of the
service that adapts the intervention in specific health contexts, together with a deployment
project and all of them particularized for the conditions of each participating organization. In
this process it would constitute a valuable contribution of the health professionals who would
act as active agents of the health process in the previous phases due to their knowledge on the
intervention and the health context, and as the promoters of complementary strategies for the
dissemination of the innovation.
2.2. Interoperability
2.2.1. Interoperability of the clinical information
The interoperability of the clinical information is one of the requirements of the health
continuity [41]. The current paradigms of the health put the patient at the centre of a process
around which are located the organizations and professionals who provide them with their
services independently of their geographical or temporary location. For this strategy to be
effective it needs the information to flow between the different nodes in such a way that it is
automatically interpretable by them. Thus the professionals will have all of the information
that they require to carry out their work, avoiding problems of duplicating the test for the
patient to increase his/her safety, statistical studies can be carried out more easily on having
the normalized information available and are able to plan the action to be carried out auto‐
matically.
Also for a platform like the one presented here, or for any other medical telecare service, this
question is essential, as one of the problems that usually comes up is that of its isolation as
regards other information systems, since on being systems created specifically for carrying out
the support work of the service, the possibility of communicating with others is not normally
taken into account and the information generated in these services usually stays in their own
storage systems, without reaching the patient’s records unless a manual introduction of the
required data is written [42]. The interoperability of these platforms, therefore, is a funda‐
mental requirement if it is required to integrate into the trends of the health continuity.
With these premises the PITES platform has been provided with an interoperability framework
to facilitate the sharing of the information between the different nodes that are connected to
the platform, as is its interconnection with other information systems such as the clinical
records of the health organizations and for the use of the information for secondary uses.
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But, what is interoperability? the ISO (specifically the Information Technology Vocabulary –
Fundamental Terms, or ISO/IEC 2382-01) defines the interoperability as the "capacity to
communicate, implement applications or transfer data between sever functional units without
the user needing to know the particular characteristics of the said units". The definition is fairly
clear, but perhaps insufficient. The first thing that has to be specified is that there are several
types of interoperability: the classic technical, syntactical and semantic; the organizational has
recently been merged, and there are authors that go further and even speak of political
interoperability, whose existence depends rather on where the limit of the definition of the
organization is placed. Let us see what each of these "interoperabilities" are.
Technical Interoperability: this is the basis on which the connection between systems is
supported. Technical interoperability defines the interfaces, both physical and logical, which
allow the aforementioned functional definition to be able to exchange information. It is
currently well advanced, since, it is not exclusive to the health scenario and its development
has been necessary for many other fields. Regulations such as 802.3, 802.11, TCP/IP, HTTP, the
Zigbee Bluetooth specification, the low levels of the ISO 11073, SOAP family, etc. are those that
are used to achieve technical interoperability.
Syntactical Interoperability: Syntactical interoperability deals with the formats of the ex‐
changed files or of the types of data used, making them able to make translations between
formats depending on those used for each system involving the communication. The systems
that only provide this type of interoperability act as mere messengers without intervening in
the content of the information communicated without being able to react depending on it. This
type of interoperability also has a high level of development, although in the health field some
evolution is still necessary. Within the range of regulations on which they are based so as to
achieve syntactical interoperability can be found XML, the specifications for types of data such
as TS 14796 from CEN or the ISO 21090, the specifications of messages of versions 2.x of HL7
or the reference models of HL7 V3 or UNE-EN ISO 13606, although the latter are also the basis
of the semantic interoperability, as can be seen below.
Semantic Interoperability: according to the definition of the 251 Technical Committee of CEN,
it is the state that exists between the two entities-applications when, with respect to a specific
task, an application can accept data from the other and carry out this task satisfactorily without
the need for the intervention of an external operator. That is, two systems will be semantically
interoperable if the information circulates between them without the original meaning being
altered and each of them understanding by itself what the other sends and is consequently
able to act. It is that which it would permit, for example, that the dispersed information of a
patient, generated in many different sources, in different places, systems and moments, may
be shared. It also needs to be at the disposal of the professionals where they need it or can be
used easily in secondary uses such as research or statistics. Contrary to what is frequently
believed, the use of terminologies to encode the information is not sufficient to achieve
semantic interoperability since clinical information consists of much more than just words. At
the times of expressing the clinical information the vocabulary is necessary, as well as being
able to express the context in which the information has been generated (who, when, with
which objective, about whom, the level of viability, etc.) as well as being able to formalize that
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which must be gathered for each concept handled so that it makes sense (it must contain a
summary of the records, a discharge report, the Barthel index, etc.). For the first necessity, the
terminologies (SNOMED-CT, CIE-10, LOINC, etc.) can be used to express the context; (UNE-
EN ISO 13606:1, RIM, CDA, etc.) reference models are used and there are mechanisms as
archetypes to formalize and share the concepts (for example those defined in UNE-EN ISO
13606:2) or the detailed clinical models (DCM).
Organizational Interoperability: summarizing considerably, it may be said that the organiza‐
tional interoperability is supported by business rules. In order for two organizations to be able
to cooperate they must share a common context in their procedures and work flows. It will be
difficult to interoperate, for example, if the definitions of the process, health plan or health
order are different or incompatibles. The definitions of some of these concepts are currently
imposed by the information systems that are used in the different organizations and that the
providers have included in their developments without previously formalizing them. Other
concepts are established by the health policies developed by the different administrations on
which the organizations depend (that is the concept that some political interoperability authors
use). There is still much more to be done in this field, although in the environment of stand‐
ardization there are works such as the EN 12967 HISA (Health Informatics - Service Architec‐
ture) regulation which, in its first part, deals with the business point of view, and mainly the
UNE-EN ISO 13940 regulation (system of concepts to give support to the continuity of the
health).
2.2.2. Definition of the Interoperability Framework of the Platform
The design of the interoperability layer of the PITES platform is dealt with by taking its
objective into account (open platform to support e-health services) such as the special charac‐
teristics of the scenario in which its activity is developed, as well as the peculiarities in Spain,
where the existence of autonomous regional governments (known as Comunidades Autóno‐
mas), with different languages and the health responsibilities transferred, conditions to a large
extent the approach to be implemented:
• PITES is an open platform to give support to a large variety of research groups belonging
to different organizations.
• The organizations participating in PITES belong to different Comunidades Autónomas with
the health powers transferred and with different languages.
• The information systems of the different nodes may be manufactured differently and be
based on different models.
• The list of organizations participating in PITES is not closed, but it is envisaged that in future
calls new nodes will be incorporated, a question that also forms part of the philosophy of
the platform. That is, the solution that is adopted for the interoperability must be capable
of incorporating new elements probably based on systems and models different from those
that currently exist.
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In such a scenario it would be very difficult to establish a rigid framework for the exchange of
information to be set, for example, a series of predefined messages to which any user of the
platform, present or future should attend, especially in the health field in which the complexity
of the information dealt with is a determinant factor at the time of finding satisfactory
communications solutions, as is also the speed of changing the domain knowledge.
In this sphere, current trends point to the use of strategies that permit the information to be
separated (which is known from a certain entity and is not going to vary over time) from the
knowledge (that which is valid for all of the entities of the domain but which is subject to
variations as the research advances or new techniques are developed). These double-model
strategies (information or reference model and knowledge model or archetypes) [43] allow, on
the one hand, the variations systems in the knowledge to be protected and, on the other hand,
separate the actions of the experts in the technical field (they develop the systems based on the
reference model) of the domain experts (the health professionals that define the concepts to be
used by means of archetypes). This is the strategy that, for example, the UNE-EN ISO 13606
regulation implements.
Under these premises, the main requirement that the standardization framework must achieve
is to provide interoperability to the information systems involved, independently of the
moment in which the scenario is used, and with the best possible impact both in the configu‐
ration of its teams and in the way of working or organizing the information. In order to achieve
it, the use of a series of international regulations has been opted for: ISO 21090 for the types of
data, UNE-EN ISO 13606 for the transfer of the clinical information and the EN 13940 regulation
as a series of concepts to give support to the health continuity.
2.2.2.1. Interoperability framework: syntactical interoperability
Syntactical interoperability strengthens the use of XML to encode the messages. This is done
in accordance with the reference model of the UNE-EN ISO 13606 regulation using the type
of information defined in ISO 21090. Given that the UNE-EN ISO 13606 regulation remains
agnostic as regards the technology (and does not define what has to be used to carry out the
final encoding), some common XML Schemas are used for the reference model created by Dr.
Dipak Kalra’s group (leader of the EHRCom task force that developed the regulation), which
is being converted into the de facto regulation, as they are currently being used in a multitude
of both national and international projects.
As regards the types of data specified by the ISO 21090 regulation [44], the XML Schema which
proposes the regulation in its informative part is used. In this case, a reduction has been made
in the types available to facilitate the implementation, always maintaining the compatibility
with the regulation, as well as the possibility of easily adding the new types that are necessary.
2.2.2.2. Interoperability framework: semantic interoperability
Semantic interoperability is supported on two pillars: the use of terminologies together with
the double reference model and archetypes of the UNE-EN ISO 13606 regulation [45, 46].
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2.2.2.2.1. Use of terminologies
The first basis for the semantic interoperability of the clinical information is the encoding of
the terms used in the domain. For this it has become necessary to use the standardized
terminologies. The proposed PITES interoperability framework, the use of SNOMED CT and
its link with the archetypes defined as one of the means of supporting the semantic interoper‐
ability [47]. This is implemented by means of the creation of the corresponding subsets of terms.
Equally, in those cases in which the use of SNOMED CT does not cover the terminological
necessities, and given that the 13606 regulation does not impose any specific terminology, the
terminologies suitable for each domain are used.
2.2.2.2.2. Reference models and archetypes
The reference model is in charge of representing the general characteristics of the components
of the ECR, how they are organized, and the context information necessary to satisfy the
requirements both ethical and legal of the register. The model defines the series of classes that
make up the constituent blocks of the register, that is, gather its stable characteristics.
Figure 3. Simplified diagram of the UNE-EN ISO 13606 model reference (obtained from (2))
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The reference model of the 13606 regulation organizes information in the following way (see
Figure 3): the summary, which forms part of a message is the container of the information
referring to a patient (the whole file or part of it) that is going to be transmitted. This infor‐
mation includes the demographic data (the identification of the people and entities are
separated from the clinic in order to satisfy legal requirements), the access policies and the
clinical information, which is organized thus: the summary contains a series of compositions
(information on the subject gathered during the meeting, a report, etc.) which are adapted to
be able to reconstruct the history of the data. The compositions store simple statements on
observations, evaluations or instructions (entry), which may be grouped together in sections
to represent the internal organization of the documents as their headings are made. Finally,
the entries contain elements, in each of which a specific datum is stored. The elements may be
grouped together in clusters to represent more complex structures of data, such as temporary
series or tables. The regulation provides a way of additional organization high level which
permits the compositions to be grouped together in folders, to be able to reproduce the
organizational criteria of each centre (per episode, per service, per meeting, etc.). The clinical
information is accompanied by another type of context information to complement its meaning
or comply with the legal requirements. Thus any component can contain information on who
completed it (audit_info), it can be signed (attestation_info) or be linked to other components
(link), to express cause-effect relationships, problem-solución, etc. It also gathers information
on the environment in which an activity is developed (clinical_session), who participated in it
(functional_role) or if the information refers to the patient or another entity (related_party).
In order to achieve interoperability, a model such as this one has to be complemented in the
knowledge domain with a formal model to transmit and share structures of predefined classes,
agreed to by a community, corresponding to fragments of the registry created under specific
clinical situations: the archetypes. An archetype is the definition of a hierarchical combination
of components or the reference model, to which it restricts (given their names, types of possible
data, default values, cardinality, etc.), to model clinical concepts of the knowledge domain.
These structures, although sufficiently stable, can be modified or substituted by other through
the evolution of clinical practice.
The knowledge model (archetype model) implements the separation of information and
knowledge and the strategy of the generation of systems to be changed. According to this new
strategy, the technological professionals build the systems based only on the reference model.
This provides protection against changes in the knowledge. If the domain concepts do not form
part of the design of the systems, it will not be necessary to update these if those change. In
the same way, the same system may be used by different organizations although they use
different documents (that is, concepts of a different domain). On the other hand, the health
professionals model the concepts of the domain using tools based on the knowledge model
that will have generated the technologies for but without the need to have a profound
knowledge of the technological artifacts on which they are based, being only concerned about
correctly defining the concepts that they use. It is worth summarizing that these models
(archetypes) can be created at any time, since the systems use them in real time to generate
requests for data in accordance with them, they verify the validity of the requests received,
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interpret them automatically from the semantic point of view, build applications for entering
data, etc.
By using this double model, it is not necessary to have a prior total agreement between the
organizations participating in the communication, since they have the mechanism of the
archetypes as a formalized way of sharing the concepts that are being used and that the receptor
is capable of correctly interpreting, the information received automatically. In Figure 4 it can
be seen how the communication process would be:
a. When system A is going to send information to system D, it will turn to a repository of
archetypes in order to obtain the model corresponding to the concepts that are wished to
be sent.
b. Using the corresponding archetype, system A will generate a message in real time.
c. The message is sent to system D, which...
d. will check according to which archetype has generated the information and will request
it from the corresponding repository (or the organization that sent the information)
e. System D obtains the requested archetype...
f. and with it, it correctly interprets the information received to incorporate it automatically
into its own storage system.
Figure 4. Communications model with archetypes
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The archetypes have to be completed with the terminologies. This process consists essentially
of the association of an element of the archetype defined by the ADL language (Archetype
Description Language) [48] to a SNOMED CT concept or to an expression following the
grammatical regulations specified in the terminological standard.
Therefore, in accordance with the defined interoperability framework, the health professionals
of the different nodes participating in the PITES platform generate the models (archetypes) of
the concepts that handle in their domain and, from this moment on, the rest of the nodes are
able to correctly interpret the messages that are transmitted. This process may be carried out
at any time to adapt the concepts to the changes in the knowledge that come about.
2.2.2.3. Interoperability framework: organizational interoperability
The interoperability of the health information is not only based on syntactical and semantic
interoperability. In its COM(2008)3282 recommendation the European Commission recom‐
mends that the member states act on different planes, the organizational between themselves,
to achieve trans-border interoperability of the health information in Europe [49]. Equally, in
the final report of the Semantic Health project that proposes a road map to achieve the semantic
interoperability in Europe. Organizational interoperability is cited as of the factors necessary
to achieve it (1).
The scenario proposed by the PITES project, in which the participating nodes belong to
different autonomous communities, with their powers transferred and, therefore, with the
capacity to take their own decisions as regard health policy and how to implement the
communications in their territory and using different languages, it becomes very similar to the
general European scenario, therefore the organizational interoperability also becomes of great
importance. This is why it is proposed to use the UN-EN ISO 13940 regulation [50]. The said
regulation defines the types of concept and the descriptive associations, as regards the health
processes with special consideration on the continuity of the care centered on the patient, and
the shared care. Its objective is to carry out a description and formalization of the continuity
of the care in the context of information systems, implying the definition of concepts and
descriptive terms that contribute to establishing a common conceptual framework that
overcomes national, cultural and professional barriers. That is why a set of concepts is designed
to represent the phenomena of the attention process, related to the subject of attention. In this
case, the focus is not on the subject in itself but on its condition or state. It applies a modeling
technique of the processes in order to identify the objectives of the process, the sub-processes
and the activities, also taking into account aspects on the resources, responsibilities and means
for patient participation in his or her own care. In those points in which social health is
necessary, there activities also appear as well as its work flow.
The regulation defines an attention organization as "an organization directly involved in the
provision of care". Within an organization of this type, the provision of health services is
modeled as a process of organization of the attention (Figure 5). This process will contain one
or more attention processes. Similarly, it will also contain an administration process and
probably a research process (aimed at improving medical knowledge) and a training process
(with the object of improving the capacities of the health professionals by applying medical
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knowledge). The health care process constitutes the heart of the health care organizations and,
at the same time, it is made up of a clinical process and a resources management process, which
is in charge of the logistic of the activity. Finally, the clinical process contains a clinical
management process, a documentation and communication process and management of the
quality of attention process. The documentation process is essential in the entire clinical act. It
is that which allows the activity to be registered and able to communicate its results to other
activities, giving support to the health care continuity.
Figure 5. Components of the organization of the attention process in accordance with EN 13940
2.2.3. Summary: the PITES interoperability framework
In summary, in the following Table 1 the interoperability model defined for the PITES project
can be specifically seen
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INTEROPERABILITY ACTIONS REGULATIONS
Syntactical
•Encoding messages in XML
•Use of a series of types of data proposed by ISO 21090
•Messages in accordance with the 13606 XML Schema
as defined by Dipak Kalra’s group and that proposed by
the computing part of ISO
•XML
•XML Schema UNE-EN
ISO13606.1
•XML Schema ISO 21090
Semantic
•Generation of subsets of terms from SNOMED - CT
•Use of other specific terminologies according to need
•Definition of the local concepts by means of
archetypes in accordance with UNE-EN ISO 13606.
•Linking of the terminologies and the subsets defined
with the archetypes
•UNE-EN ISO 13606.1:
Reference model
•UNE-EN ISO 13606.2:
Archetype model
•SNOMED-CT
* Other terminologies
Organizational
•Definition of a common conceptual framework based
on UNE-EN ISO 13940
•Definition of an inter-organizational processes based
on UNE-EN ISO 13940
•Definition of inter-organizational work flows based on
UNE-EN ISO 13940
•UNE-EN 13940: System of
•UNE-EN 13940: Processes
and work flows
Table 1. Specification of the PITES interoperability framework
3. Description of the platform
Within the ambit of new services based on telemedicine, the generic overall scenario constitutes
a heterogeneous and diverse ecosystem (Figure 6):
• Patients and citizens in different environments, With different health conditions and health
care necessities, different degrees of dependence, age and family context, different skills and
technological availability, different living and social habits, etc.
• Health and non-health professionals and with different professional profiles, different skills,
attitudes, and technological availability in their environments.
• The world of medical devices, mainly for personal and domestic use, with an enormous
diversity, a more and more extensive catalogue becoming even more essential so as to be
able to put new health care models into practice, mainly for those whose self-treatment is
the main therapeutic option
• Technological platforms of different types: health platforms, non-platforms, private
monitoring platforms, research platforms, etc. These platforms make a ubiquitous access
possible and provide personalized services in a complex environment in a solvent manner.
• Some communications networks with a high level of capillarity which makes the Internet
possible and with support by means of high-capacity, fixed wireless and digital networks
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in an environment of convergence and the provision of services on an IP protocol. In this
environment, the platforms act as elements of interrelation or an interface between them.
The users already have more and more availability to network access technology and are
familiarized with it.
Figure 6. Technological environment of the PITES platform
In this complex environment, the PITES platform is constituted as a stable public infrastructure
technology, aimed at research groups with innovation nodes located in Health Centers, with
the objective of making support possible to collaborative research and for the obtaining of
evidence on new models for the health care provision based on ICT in scenarios related to
chronic illness and dependency.
The design of the platform is sensitive to the complexity of the socio-health system and the
difficulties and limitations that the implementation process of e-services has on the organiza‐
tions. Within the framework of experimental studies, the platform provides support to the first
three phases of the aforementioned evaluation methodology of e-services, that is, authorize
the resources and infrastructures necessary to deploy interventions with minimum imple‐
mentation necessities in the socio-health organizations.
The PITES platform is designed to support research projects; not health care activity in “clinical
routine”. As a research platform it responds to several requirements different from those
platforms orientated to “clinical routine”. These peculiarities manifest themselves, on the one
hand, in a conceptual model of entities that constitute a proposal for a reduction in users,
resources and their interactions in the design process of the e-services and, on the other hand,
an architecture based on available technologies and those which are nowadays mature such
as Web technologies, SOA (Service Oriented Architecture) and the “Cloud Computing” model.
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3.1. Conceptual entities model
In the context of complex interventions it is fundamental to detect and make clear as soon as
possible which agents participate actively in the intervention and its action and interaction
mechanisms [29]. Once the said active agents are detected it facilitates the definition, design,
development, implementation, and evaluation process of the intervention itself. In this sense,
the Chronic Care Model (CCM) [51] [52] from the aspects that propose on the organization,
interaction and identification of actors, contributes a good orientation to carry out this initial
task.
The CCM has been considered a general reference model on a global level that represents an
organizational focus of the health care and tries to act as a guide for the activities aimed at
improving the quality and the management of the chronic health care. It is the most studied
model and that which has accumulated the most evidence, in more countries and health
systems, illnesses and patient collectives, and which have derived the large part of the
organizational models and models for the provision of chronic health care that have been
proposed. The CCM establishes that in any chronic patient care scenario three contexts
participate or interact: society (with its numerous resources and public and private policies),
the health system, and the health professionals and the patients as direct actors of the health
care. It is established that the improvements in the results of the chronic health care come to
light by means of productive interactions between some informed and active patients and some
prepared health teams together with a proactive attitude, which are promoted by the coordi‐
nation of additional resources at a social and health level. In this sense, the CCM specifies six
categories of resources: the policies and social resources, the organization of the health care,
help to self-management, the systems of provision of health care and help in the decision and
the clinical information systems. Thus, it implicitly establishes a classification of entities from
which it is possible to identify the agents participating in the interventions aimed at an
improvement in the chronic health care. The patients and health professionals are always active
agents of direct participation in any intervention, and the rest of the resources are agents or
optionally active subsystems (they do not need to be present in all of the interventions) that
play a support or promoter role.
Taking the focus of the CCM as reference in the design process of the e-services, the PITES
platform establishes a conceptual entities model that constitutes a user abstraction proposal,
resources and their interactions. The model (Figure 7) is made up of six entities: patient entity,
health care professional entity, external resource entity, health care information system entity,
intervention management entity and technological platform entity. Each of the conceptual
entities of the model represents a view or perspective of the health care provision model that
is wished to evaluate by means of the intervention.
The patient entity encompasses the patient and all of the resources assigned to him or her for
the intervention. The patient entity is usually made up of:
• A patient protocol usually consists of periodically carrying out biometric measurements
(arterial pressure, weight, pulse, ECG, spirometry, lipid profile, activity, etc.), and replies
to questionnaires on symptoms or actions.
PITES: Telemedicine and e-Health Innovation Platform
http://dx.doi.org/10.5772/57021
187
• Some biomedical monitoring equipment for personal use (sphygmomanometer, pulse
oximeter, scales, thermometer, etc.) or environmental monitoring, to carry out the meas‐
urements required by the patient protocol
• Communications equipment to carry out the periodical sending of protocol information.
The equipment must be suitable to interact with the interfaces authorized by the platform.
The health care professional entity represents the perspective of the health professionals and
is made up of the series of tools and resources required to carry out the health care protocol
established by the intervention. In general, it is applications adapted to the specific patient
protocols by means of which the monitoring is carried out including help tools and function‐
alities that make an indirect communication possible with the patient (advice, warnings, etc.).
These applications are usually accessible by means of the Internet with the appropriate access
controls. The reply messages to the patients are sent by means of personalized services such
as SMS, e-mail, interactive voice systems, etc.
The external resource entity represents any support resource additional to the intervention on
the health or community environment. That is health centers, pharmacies, consultations,
geriatric residencies, other platforms, etc. The function of this entity is usually to represent any
infrastructure that acts as a resource shared between patients, because it supposes some type
of logistic advantage (economical, location, etc.). They can act as external resources, for
example:
Figure 7. PITES conceptual entities
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• Residential homes, in which there is the possibility of attending the patients collectively by
means of shared equipment, for example, patients with oral anticoagulation therapy who
share the INR monitor and the communications equipment. The interfaces with this type of
external resource may be applications based on the Web, designed so that a person respon‐
sible manages the patient collectives.
• Platforms for external monitoring that receive information of specific patient collectives, for
example, a collective of patients with implantable cardioverter-defibrillator (ICD) moni‐
tored from a platform that authorizes the company providing the ICD. In these cases, the
interface would be based on specific “middleware” that makes it possible to interoperate
with the said external platform.
The health care information system entity essentially represents the Electronic Clinical Records
of the Patient and the perspective from the health information systems. The function that this
entity contributes is that of making it possible to exchange clinical information on the said
systems and the ECR essentially summarized clinical information generated by the patients
and health professionals during the interventions. The interfaces with the ECR entities are
based on “middleware” specific to interoperate with the said information systems in accord‐
ance with regulations.
The intervention management entity supports a series of roles and resources that are required
to carry out the intervention and that are not available or cannot be carried out suitable either
by the health system or the community. The services provided by this entity are of two kinds:
• Support to the deployment of the intervention: it provides resources to make it possible to
train the health professionals, patients, families; resources for the maintenance and man‐
agement of the equipment used; tools for the monitoring of the compliance with patient
protocols, etc.
• Support methodology of the experimental evaluation study: it provides resources for the
support methodology of the clinical trials and experimental studies. For example, drawing
up and management of the documentation (Case Report Forms), applications for the
Electronic Data Capture, services for the centralized randomization, recompilation and
analysis of results, among others.
The Technological Platform Entity represents the ICT nucleus that supports the functional
interfaces, the coordination of activities and finally the telematic infrastructure that require the
interventions to be implemented during its evaluation. The services provided by the platform
are provided mainly by means of the Internet, digital cellular networks or basic telephone
network; the architecture of the platform is described in the following section.
When it is desired to evaluate the health care provision model with the support of the platform,
the steps to be followed are as follows: define the intervention that leads to the practice of the
health care model and the experimental evaluation study (type of study, variables, measure‐
ment instruments, dimension of the study as regards the sample and duration of the inter‐
vention, etc.) and define and design the new e-service which will give support to the
intervention. To carry out this second stage, the actors involved must be determined (direct
PITES: Telemedicine and e-Health Innovation Platform
http://dx.doi.org/10.5772/57021
189
and indirect); this datum will establish the entities of the conceptual model that participate.
Below, from the perspective of each of the participating entities, we have to establish:
• the specifications of the interfaces, applications and services based on the roles that each
participant contributes in the health care process,
• the interactions with the patient as subject of the health care and their environment,
• the temporary aspects of the provision of health care,
• the organization and management of the health care, the aspects of support to the decision
and monitoring of the activity, and
• the aspects related to responsibilities, flows and management of the information.
Finally, the provision model establishes an organizational and functional framework to which
the intervention and experimental evaluation study must be adapted, to be able to carry out a
joint deployment which may be supported by the PITES technological platform, and therefore
develop it in the context that establishes that of the evaluation methodology.
3.2. Architecture
As has already been said, the PITES platform is a platform for research, not a support to health
care activity in “clinical routine”. As a research platform, its design responds to some require‐
ments that are additional to those adopted by the platforms oriented to “clinical routine” and
which condition architecture decisions.
The platforms oriented to “clinical routine” must provide greater attention to aspects such as
scalability maintainability and availability. The research platforms, also:
• Must be conceived from their basis in order to change, evolve and interoperate;
• Must contemplate intrinsically evaluation mechanisms in the widest sense, and
• Must be capable of coexisting with the “clinical routine” platforms to make the mutual
interaction possible together with the progressive implementation of e-services.
Under these conditions, the requisites demanded by the PITES platform and which constitute
the references for the design of its architecture, are as follows:
• Functionality independent of the technological infrastructure of the environment in which
the e-services are going to be deployed: the platform must guarantee some homogeneous
functional deployment conditions during the evaluation of the interventions, especially on
those that imply geographical dispersion so as to be more sensitive to this aspect
• Scalability: the platform must be capable of supporting from small pilot projects and concept
trials, up to multi-centered interventions that involve hundreds of users (patients, profes‐
sionals, etc.).
• Dynamism and flexibility: the platform must have the capacity for rapid adaptation and
evolution, the incorporation of new functionalities and the reuse of components, incorpo‐
ration of technological opportunities, etc.
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• Operative transparency in the access and location of the resources: the platform must deploy
the services in such a way that they are perceived by the users as incorporated or integrated
in the socio-health care. This requirement is of greater relevance during the evaluation
phases on clinical effectiveness. In the said phases, the platform must not constitute an
element that commits the validity of the studies
• Interoperability: capacity to interoperate with heterogeneous components, distributions,
inherited, other platforms/devices. The interoperability is contemplated in a wide sense
(syntactic and semantic level) and tied to the conformity with regulations.
• Robustness, safety, maintainability and high availability: just as in a clinical routine use, the
platform must maintain operating production conditions in experimental studies whose
interventions can be extended for months, even years, as well as having the capacity to
support multiple interventions simultaneously
• Conformity with international regulations and developments based on “open-source”
software: both as recommendations of the European interoperability framework and of the
WHO for e-health [53]. Conformity with regulations is an essential element to have gener‐
alizable and interoperable solutions, as well as a promoter factor of the success in the
implementations and a reduction in costs. Questions related to the regulation in the
exchange of data (ECR), and the interoperability between platforms/devices must be
attended to.
These requirements are currently completely reachable by means of available and mature
technologies such as:
• The Web technologies as a series of services associated with the Internet for the provision
of e-services to users and interoperability support;
• SOA as an architecture paradigm to implement open systems and distributed services
• The “Cloud Computing” model, as a paradigm for the provision of services and technologies
through the Internet, which in collaborative research environments such as PITES, allows
the platform to be able to act as a “hub” for the dynamic provision of services
• A basic Internet network infrastructure based on the current convergence of the ubiquitous
provision of services on IP networks.
With the support of these technologies and from the requirements, the platform has been
designed as an open system of distributed services on communications based on the IP
protocol. Any e-service supported by the PITES platform adopts an architecture oriented to
services (SOA) and design paradigms established on the web 2.0: weak connection between
services, interfaces based on “web-services”, “hybrid” web applications (mashups), etc. As
additional priority directives, the developments on the PITES platform must be based on
“open-source” and obtaining conformity with international regulations.
The architecture of the platform is distributed on two levels (see Figure 8):
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• the “front-end” of the platform, that encompasses the interaction mechanisms of the
platform with the users of the system, that is, the interfaces of the entities (people or other
platforms/services), and
• the “back-end”, which constitutes the heart of the platform in which the structure has been
defined, integration, and interdependence of the internal components of the platform and
those of the “front-end” components, that is, the support of the logic of the e-services that
support the interventions
Figure 8. Architecture of the PITES technological platform
The “front-end” interfaces are based on applications, services and protocols based on Internet
and digital cellular networks and commutated telephone networks. The platform, has a base
services to support these types of intervention by means of content, server, Web SMS gateways,
IVR system(Interactive Voice Response), TTS services (Text-to-speech), services ASR (Auto‐
matic Voice Recognition), streaming server managers, etc.
The design of the platform in “back-end” adopts an architecture oriented to services in two
layers:
• “Business layer”, in which the functionalities/services specific to the support of the inter‐
ventions, the business logic of the applications and services directly linked to each inter‐
vention and which implement the requirements proper to them are deployed
• “Application layer”, where the additional services with functionalities of a special and
specialized character and oriented to its use by the services of the “business layer” and of
the "front-end" are located. The objective of this layer is to constitute an extendable, diverse
and detached series of functionalities that give support to the e-services supported by the
platform in the research projects. The provision of these services is transparent and with
open interfaces based on “web-services” (SOAP and REST on HTTP/HTTPS protocols).
These support services can be made public (beyond the PITES community) by moving the
access interface to the "front-end" layer.
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From the point of view of the users to whom they are aimed, the support services and
applications for the platform are of two types: those directed to the users-person, that is,
patients, health professionals, health carers/caretakers or families and support staff for the
experimental studies, and those directed to the users-machine, that is, to other platforms,
services or monitoring devices.
The architecture adopted for the user-person applications follow a “mashup” model based on
three components:
• client application, in the "front-end" of the platform, based on different technologies: WWW,
WAP, J2ME, SMS, VoiceXML, accessible from commercial devices such as PC, conventional
or mobile telephones, "smartphones" (Android), IP telephones, etc. These applications are
located in the "front-end" of the platform
• The “mashup” component also in the "front-end", whose function is the addition of
information for the creation of enriched content destined for the client applications. These
services interact with the providers of the content in the “front-end” and “back-end” by
means of open interfaces based on Web services.
• The providers of the content, made up of the “back-end” services of the platform correspond
to the intervention in the “business layer” or services of the “application layer”. They may
also be other services content providers located in the “front-end”.
The services of the platform designed to interact with the user-machines are those directed at
monitoring devices and external services platforms (health or non-health). They have a classic
“middleware” architecture so as to eliminate heterogeneous points with the external entities,
brought about by the manufacturer’s or third-party software, networks or different commun‐
ity protocols. The “middleware” is implemented by means of “gateway” type services specific
to each case. These “gateway” type services can be assimilated as new “application layer”
services in the "back-end", so that in this way they are available to new services in the “business
layer” or "front-end" applications and therefore for any e-service that requires it.
The  following  example  is  proposed  to  illustrate  the  functioning  of  this  architecture,
consisting of the architecture required for a remote activity monitoring e-service of ICDs
(Figure  9).  Imagine  that  we want  to  evaluate  the  clinical  effectiveness  of  a  remote  ICD
monitoring service by means of an experimental study. The objective would be to meas‐
ure the possible improvement in the health results  of  a group of patients to whom this
type of monitoring is carried out (intervention), as opposed to another group in which a
conventional  monitoring is  based on hospital  visits.  We suppose  that  there  is  a  remote
monitoring platform deployed by the manufacturer of the ICD that gathers the informa‐
tion generated by these devices and stores it  in its  information system (ICD Monitoring
Platform). The health professional needs to periodically analyze the activity generated by
the  ICDs  in  the  patients  of  the  intervention  group  and  combine  it  with  other  clinical
information through other means. As well as this, the health professional needs to be able
to  send messages  to  these  patients  to  give  them advice,  warnings,  etc.  As  the  study is
framed within a clinical trial, the health professional needs to be able to carry out a random
assignment of the patients in an flexible and safe manner before being included in the study
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as well as guaranteeing an anonymity of the identification of the patients every time it is
necessary  to  get  access  to  their  demographic  information  by  searching  the  information
system of the hospital. Finally the health professional has to periodically send a summa‐
ry of the clinical activity generated in the study to the ECR of the patients so that it does
not become isolated in the platform that supports the intervention.
Figure 9. Example of the ICD e-service monitoring architecture
Within the framework of the architecture of the PITES platform, for the health professional, a
client application would be implemented based on the Web to which it would be accessed
securely (access control and HTTPS protocol). This application (client application) would be
managed by a "mashup", component in the "front-end" of the platform that provides it access
to the different sources of distributed data:
• a gateway service at the "front-end" based on "middleware" (Gateway ICD) which has the
capacity to access an external monitoring ICD platform in such a way that from the client
application client, the health professional can obtain information on the ICD activity of the
patients of the intervention group
• a gateway service in the "application layer" of the “back-end” (SMS Gateway) which permits
the sending of SMS messages. This gateway service consists of a “middleware” which
manages the transactions with the SMS Center of the mobile telephone provider
• a gateway service in the “application layer” of the “back-end” (Demog Gateway) which
permits access to the demographic information of the patients located in the information
system of its organization. On the one hand, the "middleware" accesses the said system by
means of a proprietary protocol and, on the other hand, as regards the platform, it authorizes
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an interface based on the ISO EN 13606 regulation that standardizes access to this informa‐
tion.
• a gateway service in the “application layer” of the “back-end” (EHR Gateway) which
permits the sending of summaries of the clinical activity generated by the users during the
intervention to the ECR of the organization. Once the clinical information is validated by
the health professional, the gateway receives an extract in accordance with the a ISO-EN
13606 regulation by means of an interface based on Web services which contains the said
information and which the "middleware" sends to the hospital information system through
the established protocol.
• a service in the “business layer” of the “back-end” (Service Intervention) that established
the operating logic of the intervention managed by means of data bases and processes
aspects specific to the intervention
• a gateway service in the “application layer” of the “back-end” (Random Gateway) which
permits access through an interface based on Web services to a centralized randomizing
service making the robust distribution of the patients in the two established assignment
groups possible.
The application of the health professional has access to a specific service in the “business layer”
(service intervention), to a specific service in the “front-end” (ICD gateway) and to four services
oriented to general use within the “application layer” of the “back-end” by means of his or her
“mashup” component. While the client application together with the "mashup" component´,
the service located in the “business layer” and the gateway ICD, are specific to the intervention,
the gateway services of the “application layer” are also resources accessible for any other
intervention that supports the platform. As an additional element, it is evident that to carry
out the implementation of the study, the minimum is to commit resources to be contributed
to the structure of the health organization.
The SOA architecture of the PITES platform makes it possible for the services that are initially
specified for an intervention to be able to be promoted to services of general use because of its
interest, use, and functionality. The weak connection between the services through the Web
services interfaces allows functionalities to be added or taken away with relative ease.
Following the “cloud computing” paradigm, these services can be used and evolved for future
experiments in the PITES community, even making them accessible to the global community.
This possibility gives the platform a significant advantage in the promotion of collaborative
research in this field as well as being able to put the progressive implementation strategies into
practice so that the platform can act as a temporary support to platforms in “clinical routine”.
3.2.1. Component hardware
The PITES platform has an autonomous functioning (without the need for operators) on a 24x7
regime. The platform is accessible through Internet by means of a redundant link and has the
capacity to establish point-to-point VPN with other networks. In order to achieve this de‐
manding working regime, there is a robust telematic infrastructure available in many of its
components (communications, storage).
PITES: Telemedicine and e-Health Innovation Platform
http://dx.doi.org/10.5772/57021
195
The platform consists at the physical level of a segmented Internet-accessible network
including: 9 physical and virtual servers (Xen) on IBM xSeries equipment over Linux OS (Suse
Linux Enterprise); SAN/NAS (IBM N3600) redundant storage networks; backup library
systems (TSM and IBM System Storage TS3200 Tape Library).
As basic support for e-services the platform provides a number of different general services:
WWW service (Apache), DBMS (MySQL, PostgreSQL), applications managers (Tomcat),
content managers (Drupal, LifeRay), “e-learning” server (Moodle), VoiceXML/IVR (VXI*/
Asterisk) service, TTS/ASR (Verbio) engines.
The platform includes security elements at different levels: control access (physical and
telematic) policies, (storage and communications) redundancy and monitoring tools (Nagios/
Cacti).
3.3. Services
The specific services currently provided by the platform include:
Messenger service: telematic service accessible through the Internet which implements the
possibility of sending short SMS messages, usually from the health professionals sent to the
patients for notifications, warnings, advice, etc. The service interacts with the SMS Centers of
the telephone operators via GSMs available on the platform.
Two conditions are demanded from the SMS service:
• that the SMS messages are delivered to the addressee and if not, get notification that it has
not (together with the causes) and
• that the SMS messages are delivered after a certain period of time so that the validity of its
content is not indefinite.
Obviously the SMS service offered by the GSM is highly reliable although none of the two
conditions demanded can be guaranteed 100%. However, the SMS service has mechanisms
available that make it possible to know the current state of the SMS messages together with
the occasional incidents that could take place in transit to the destination terminal. The SMS
Centers offer the possibility of sending reports to the sender on the progress of the SMS (DLR,
Delivery Reports). By means of the DLR request by message, the SMS service of the central
station is capable of knowing whether a message is still in transit, has been delivered to the
addressee (with time and date of receipt), or not or has been eliminated (together with its
cause).
Equally, the SMS service is capable of establishing the period of validity (“validity period”) of
each message, exceeding which, if it has not been delivered to the addressee, it instructs the
SMS Center in order to eliminate the said message from its lists (accompanied by the corre‐
sponding DLR report). The period of validity chosen depends on different factors and can vary
from just a few hours to several days; its choice for example, in the case of communications to
patients, depends on the medical protocol followed in the specific scenario. However, it is not
a critical aspect in other types of task, and the default expiry period is not extended.
Telemedicine196
Another limitation of SMS messages is the nominal limitation in the total number of characters
that can be included in each message, and which is fixed at 160. This length is very limiting in
the majority of notifications from the doctor to the patient. It is also impractical for the doctor
to send consecutive messages to the patient referring to the same matter (one of them might
not arrive or arrive in the wrong order, etc.). However, there is the technical possibility of
generating messages that are longer than usual ( “long SMS” calls) and which are segmented
at the origin and later reassembled by the patient’s mobile telephone in a way transparent to
the user, and therefore permitting the sending of arbitrarily long messages. This functionality
is supported by the SMS service of the platform.
Functionally, access to the SMS messages server is carried out by means of the HTTP/
SOAP1.1/1.2. “web-services” interface. In each request to send, the following is indicated:
addressee of the message, text of the message, need for confirmation of delivery, period of
validity and preferred time period for sending the message (or immediate delivery). Once the
request is accepted a univocal identifier is generated with the service applicant and the sending
procedure commences with an adjustment of the parameters of the message (establishment of
the output queue, internal register, etc). The SMS service is in charge of sending the message
through one of the available GSM modems. From the moment of sending the message to the
corresponding SMS Center, the progress of the SMS is monitored through to the reception of
the corresponding DLR. Before the arrival of each DLR message, the SMS messages server
analyzes its content and notifies the state to the corresponding service that requested its
sending in such a way that the state of the messages can be known at all times.
By means of a widely available mobile service, this service authorizes, by means of an open
interface, a way of indirect communication between health professionals and patients with a
high level of security (delivery security and range of validity), and personalization (flexibility
in the size of the message and the establishment of the preferred period of time for delivery).
Randomizing service: telematic service accessible through the Internet that implements
support to the randomizing process of clinical trials in a centralized way. The service deploys
the following functionalities:
• Simultaneous support to randomizing in multiple studies
• Complete management of the randomizing process by the promoter of the clinical trial
• Randomizing support in different modalities: simple, by block, stratified, centralized and
blind
• Assignation lists of up to 6 groups with the capacity for self-replication
• Control of transactions to guarantee the integrity for the applicants of the assignation
• Generation statistics of the randomizing progress upon request
The service establishes three levels of privilege (overall administrator, project administrator,
project user):
• The “overall administrator” user (level 1), has the capacity to create new projects and
administer the functioning of the overall service; each project corresponds to a clinical trial.
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The process of creating a new project has the aim of authorizing the permission, structures
and data necessary for its configuration in the service. Once the new project is created, the
figure of the administrator “project administrator” already associated to a specific study is
established.
• The “project administrator” (level 2), has the capacity to create the structure of the process
of randomizing the clinical trial: total sample, number of assigned groups (identified
successively by: A, B, C, D, E, F), variable block sizes (multiples of the number of assignation
groups), and the stratification tree (if required). The “project administrator” has the capacity
to open/interrupt/close the randomizing process, and request progress statistics on the
randomizing (overall, by time intervals, by stratum, etc.)
• The “project user” (level 3), whose function is basically to request the assignments to groups
in a specific study.
The service does not establish limits on the studies in relation to the total number of stratifi‐
cation levels. A random assignment list is generated for each stratification branch with as many
assignment groups as have been established to guarantee the assignment balance in groups of
varying sized blocks. Each randomizing request that the service carries out is associated to a
transaction identifier which the service may propose or generated dynamically, in such a way
that it is possible to control each assignment individually in relation not only to the activity
register but also the recovery in real time of errors in the process. The randomizing service
includes internal functionalities for the register of auditing in each clinical trial. In relation to
the generation of the project and the assignment tables, the randomizing seed is stored which
makes it possible to guarantee the integrity of the assignment lists and their reproduction. It
also generates a series of daily files on the degree of activity and functioning of the server,
created and updated dynamically by date/time/project/user access/action carried out.
The service is accessible through an interface based on Web services by means of the SOAP
(1.1/1.2) protocol and transport on the HTTPS service. This randomizing service has the
advantage of basing its functionality on an open interface for the integral management of the
process. This approximation makes it possible to promote the clinical trial, design and develop
client applications in the measurement of their requirements and resources, incorporating the
randomizing process transparently as another element/service in the management of its
clinical trial.
Clinical information service: telematic service which stores and retrieves clinical information
compliant with the ISO EN 13606 standard. In is based upon a web services structure with two
groups of functionalities: the input of information and its querying/retrieval. The input of
information is performed through an interface compliant with part 5 of the standard which
accepts extracts codified in XML. The service processes the received information before storing
it in order to obtain features which permit to classify it and enable its ulterior querying and
retrieval. To do so for one side complete extracts are stored (preserving the integrity of the
information) and for the other a relational database is built where the obtained features are
kept in order. The querying/retrieval of information presents three options:
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• Querying of the information through a graphical interface: the user, after identification, has
access to a browser which permits him or her to navigate through the information, but only
to that part on which it has permissions depending on his/her role (access control compliant
with part 4 of the 13606 standard). This functionality makes use of the archetype server
service in order to obtain those used in the generation of the information and be able to
present the data in a complete manner and in the language or using the terminologies
desired by the user (if they are defined and mapped in the archetype).
• Retrieval of a patient’s information: web service which permits to request a given patient’s
information using an interface compliant with part 5 of the standard. Through this service
the user can request (utilizing other application, service or system) the whole information
stored in a person’s record or a part of it, obtaining an extract with the requested composi‐
tions and complaining the corresponding access restrictions.
• Information queries: the service also offers the possibility to pose specific queries oriented
to the statistical processing of the total population in the repository and yielding numerical
results about prevalence of diseases or concurrence of problems.
Archetype repository service: telematic service which stores and retrieves archetypes compli‐
ant with the model established in the standard: archetypes are transferred in text files codified
in the ADL language and using an interface compatible with part 5 of the 13606 standard. The
system stores archetypes according the reference model normalized in part 2, which enables
to perform searches using any identification data or any state of the archetype and also through
the meaning of the nodes (specified as restrictions to the RECORD_COMPONENT class of the
reference model of the extracts) defined in it. The retrieval/querying of archetypes permits two
possibilities:
• Retrieval of archetypes: following the specifications of the interface defined in part 5 of the
standard this automatic service enables to retrieve archetypes through its identifier, concept,
terminology, language or those that are specializations or have been specialized by another
archetype. This service is oriented to its use by other services, applications or even other
external systems.
• Archetype querying: the server offers a web graphical browser for users to navigate through
the archetypes repository; to query them through concept or type; see their specializations
and download them to be used in their own projects.
Following the philosophy of the double model in the standard, this service permits the
archetype querying in an open fashion.
Demographic information service: this service stores and provides demographic information
of the entities involved in the clinical information systems. It is based upon the demographic
information model included in the reference model of part 1 in the standard; this permits to
deal with persons (patients and health professionals) and also with organizations or devices
and programs in use. This service keeps track of all the identifiers assigned to each entity,
including official entities but also those assigned internally by organizations, for instance in
specific projects. This working method allows to separate demographic information from the
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rest of data facilitating to make information anonym. For security reasons this service is not
accessible from the outside of the platform so that its possible clients may only be its running
applications or other supplied services.
Anonymisation service: this service enables to make anonym clinical information to be used
in secondary uses such as research or statistics. This service accepts and returns extracts
compliant with the standard reference model, codified in XML. Received extracts are analyzed
to suppress the identification of the patient including demographic information codified in
class IDENTIFIED_ENTITY of the reference model, even though the year of birthday (not
including day and month) and the sex of the patient may be preserved for statistical purposes.
To do so, a new randomized identifier is assigned and substituted in the extract. This service
makes use of the demographic service in order to maintain a record of the identifiers in use so
that if further information about the same patient arrives its identifier can be assigned and the
health information repository remains coherent. For this reason it is possible to install this
service and the demographic service in the client side so that the information about the person
does not leave the organization where it was generated and the clinical information is
presented anonym to the outside world.
4. Results of the platform
Projects supported by the PITES platform since 2004 are described below. The list is not
exhaustive. Those that have been considered as of greater interest have been included. From
2009 the platform has been open to other Spanish research groups.
4.1. Finalized projects
• Impact of Patient–General Practitioner Short-Messages-Based Interaction on the Control of
Hypertension in a Follow-up Service for Low-to-Medium Risk Hypertensive Patients: A
Randomized Controlled Trial. (FIS 01/0915. SEP 1201/02. AIRMED II Program). [54]
– Main objective. To evaluate a telemedicine system for Primary Attention; improve the control
and monitoring of arterial hypertension. Secondary objectives: Measure its effect on perceived
health and anxiety.
– Type of study. Multicenter randomized controlled trial. 285 patients were enrolled by 38 GPs
from 21 health centers in four different health areas in Madrid, Spain. October 2004-June 2006.
Intervention period, 6 months.
– Description intervention. The coordination office set up appointments with the patients of
both the TmG and the CG for training in self-blood pressure monitoring (SBPM) and the use
of the digital sphygmomanometer (both groups) and the telephone (only TmG). During the
six-month follow-up period, the TmG patients sent their mean self-measured SBP (sSBP) and
DBP (sDBP), based on three measurements made at 3-min intervals under fasting conditions
in the morning and at night, four times a week (Monday and Thursday, morning and night),
and their pulse rate and weight once a week. During each WAP session, they had the option
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of responding to a simple questionnaire. At some later moment, with no obligation imposed
by the protocol in terms of frequency of access to the CS, the GPs accessed the data sent by
their patients via the Web. According to his or her own criteria, the GP could send an SMS
regarding any related issue to the patient’s phone. The CG patients followed the same SBPM
protocol, with the exception that the results were recorded on paper in a data collection
notebook; they sent no data to the CS, and thus, had no interaction with their GPs. They
continued to make their scheduled visits to their GPs at their corresponding center, as they
had done prior to the study.
– Study variables. The main outcome measure, referred to by us as the degree of hypertension
control, was the percentage of patients who were not optimally controlled at the time of the
final visit. Optimal control was defined as a mean of three arterial pressure determinations
carried out by a professional during the final visit, resulting in pSBP ≤ 140 mmHg and pDBP
≤ 90 mmHg. The secondary outcome measures were: 1) the changes in pSBP and pDBP between
the initial and final visits measured in the office of the GP; 2) the changes in the mean self-
measured sSBP, sDBP, and HR throughout the intervention period; 3) the changes in the
dimensions of the brief profiles of the SF-36 Health Survey physical component summary
(PCS) and mental component summary (MCS) and in the state anxiety (SA) and trait anxiety
(TA), according to the State–Trait Anxiety Inventory (STAI); and 4) the number of consultations
and hospital admissions in the two groups.
– Results. A) Degree of hypertension control. The number of patients exhibiting poor control
at the final visit, was the case in 31.7% of the patients in the TmG and in 35.7% of those in the
CG, (difference: 4.0%, 95% CI: −7.0% to 14.9%) there being no significant difference (p = 0.47).
B) Change in hypertension during follow-up. In the comparison of the measurements carried
out by the GPs at the initial and final visits, the TmG presented a decrease in pSBP of 15.5
mmHg and a decrease in pDBP of 9.6 mmHg, while in the CG, the pSBP decreased by 11.9
mmHg and the pDBP by 4.4 mmHg, decreases that did not differ significantly (pSBP: p=0.13;
pDBP: p=0.40). The mean values for self-measured sSBP, sDBP, and HR (TmG: 131.6, 78.7, 70.1;
CG: 132.4, 78.0, 69.7) throughout the six-month period, calculated according to the area under
the curve, were not significantly different between the two groups (sSBP: p = 0.52; sDBP: p =
0.50; and HR: p = 0.79).
– Comments. There are no significant differences between the two groups in terms of the
degree of hypertension control, measured as the number of poorly controlled patients at the
final visit, given that the intention to treat analysis adds those that dropped out prior to the
initial visit (TmG: n = 11; CG: n = 1) and those occurring during follow-up (TmG: n = 4; CG: n
= 10) to the number of poorly controlled patients who underwent follow-up (TmG: n = 30; CG:
n = 40). However self-blood pressure monitoring brings about improvements in hypertension
control, given that the percentage of controlled patients in the final visit is greater in TmG. The
reduction obtained in pSBP and pDBP in the TmG are consistent with the values reported by
other authors, independent of the intervention selected.
• Evaluation of a Telemedicine-Based Service for the Follow-Up and Monitoring of Patients
Treated With Oral Anticoagulant Therapy. (FIS 02/1156. SEP 1201/02. AIRMED II Program).
[55]
PITES: Telemedicine and e-Health Innovation Platform
http://dx.doi.org/10.5772/57021
201
– Main objective: To find out the acceptability and satisfaction of the patients who have a
supervised system of self-controlled INR measurement, with home follow up by means of
telemedicine based on mobile telephony within the ambit of Primary Attention. Secondary
objectives: To determine the degree of control suitable for oral anticoagulant treatment
achieved by patients, users of the system. To describe the eventual factors which condition a
bad control. Clinically relevant possible accidents (hemorrhage and thrombosis) suffered by
the patients in the study.
– Type of study. Quasi-experimental study, with two differentiated groups. 108 patients
included in a Health Center in Pozuelo, Madrid, Spain. December 2004 -March 2006. Inter‐
vention period, 12 months
– Description intervention. The patients in the TmG were trained in the use of the coagulometer
and the cellular phone by staff from the coordination office. At the beginning and end of the
study, the patients in both the groups completed the quality of life questionnaire specific to
anticoagulated patients designed by Sawicki; the SF-12 quality of life questionnaire for
application in the general population; and the STAI to assess anxiety. The patients in the TmG
measured their own INR every 3 weeks if they met the criteria for good control; otherwise,
their GP proposed the date for the next determination and modification of the TWD. After
each self-measurement, the patients sent their INR values and responded yes or no via a safe
WAP session, to questions concerning another six clinical parameters, such as omission or
duplication of doses, ingestion of new drugs, alcohol intake, changes in diet, fever, and
intercurrent diseases, in order to define the causes of poor control.
– Study variables. Data on safety and the degree of control: a) Number of determinations made
by each patient and their correlation with adequate INR control; b) number of determinations
falling in and out of the target INR range, with the possible reasons for poor control; c) time
during which each patient was in or out of the target INR range, measured using standard
methods-–linear interpolation and in or out of range; and d) the incidence of adverse events
associated with OAT (death, hemorrhagic complications, and thrombosis) in the two groups.
Data concerning the acceptability of the change: a) The degree of compliance with the protocol
in the TmG, measured both in the patients and the GPs and b) changes in the results of the
three questionnaires provided at the beginning and end of the study.
– Results. (A) Degree of INR control. There were no significant differences between the two
groups in terms of INR control. In all, 57.6% of the determinations in the TmG and 60.1% of
those made in the CG were within this range. The patients in the TmG were in the target range
(linear interpolation method) 65.4% of the time over a mean participation in the project of 329.4
days. In the CG, the patients were within the range 68.0% of the time over a mean duration of
participation of 310.1 days. For the same variable measured by means of the in or out of range
method, the rates were 66.6% in the TmG and 68.9% in the CG, over the same mean partici‐
pation time. The number of INR determinations within the target range, the number of days
spent within the range according to the two conventional methods, and the distance, defined
as the deviation of the INR determination from the center of the range for each patient, were
also assessed. (B) Deaths, Complications, and Hospital Admissions. There were three deaths
in each group; there were no major complications in the TmG and only one in the CG. There
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were six minor complications, four in the TmG and two in the CG, and three cases of throm‐
boembolism, one in the TmG and two in the CG. In the TmG, there was one hospital admission
associated with OAT versus two due to other causes; in the CG, the incidence was three versus
one, respectively. (C) Acceptability of the Change. With the exception of two patients, who
received no help from the family and rejected the proposal for fear of being incapable of using
the coagulometer and the cellular phone, all the patients were capable of self-testing and
remained active in the project throughout the entire intervention period. The training sessions,
held in groups of five patients, were approximately 2 h long, and were followed by a prereg‐
istered period of 1–2 weeks. In five cases, the INR measurement and WAP sessions were always
carried out by a relative; in three cases, the patients did not even attend the training sessions,
given their instability.
The patients in the TmG determined their INR on or around the date that had been indicated
by the GP; 45.5% of the determinations were carried out on the designated day and 74.8% were
carried out within 3 days, either before or after, of that date, indicating a high rate of adherence
to the protocol, despite the freedom granted to the patients.
The degree of compliance on the part of the GPs, measured as the time elapsed before they
responded to a message from a patient, was very high; 48.5% of the total weekly dosage was
sent on the same day and 43.8% within 3 days of the reception of the message.
– Comments. The e-service exhibits highly positive features in terms of acceptability of the
procedure, satisfaction, and quality of life, and reduces the number of visits to the healthcare
center.
• Evaluation of a Telemedicine Service for the Secondary Prevention of Coronary Artery
Disease. (TSI2005-02682. FIS PI05-1882. Programa MOBIS). [56]
– Main objective. To analyze the efficacy of a new telemonitoring system for the following up
of patients with coronary heart disease (CHD), connecting patients, provided with self-
measurement devices, and care managers through mobile phone messages over the Web, and
integrating the monitoring of several cardiovascular risk factors (CRF), as a toll for secondary
prevention.
– Type of study. A single-blind, randomized controlled, clinical trial. 203 acute coronary
syndrome (ACS) survivors, was conducted at a hospital in Madrid, Spain. December 2007 -
January 2010. Intervention period: 12 months.
– Description intervention. TmG patients were temporarily provided with an automatic
sphygmomanometer, a glucose and lipid meter and a cellular phone, and support staff if
needed, were taught to measure their blood pressure (BP), heart rate and weight (weekly), and
glucose and lipids (monthly), and to send the results through their mobile phones following
a structured questionnaire (WAP session). A cardiologist accessed the biological and clinical
data via a secure Web application and, through this application, sent individualized short
message service text messages with recommendations to the patients. At exit, subjects in the
TmG completed an additional questionnaire to evaluate satisfaction with the program.
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– Study variables. Outcome measures were resting BP, body mass index (BMI), smoking status,
LDL-c, and glycated hemoglobin A1c (HbA1c), all measured at the initial and final visits for
comparison. Their smoking status was determined by self-report and confirmed by a 1-step
cotinine immunoassay in urine. The primary outcome was cardiovascular risk improvement
(CRI), defined as the proportion of patients who achieve the goal of treatment in at least 1 CRF
without exacerbation of any of the others. Treatment goals were as follows: (1) smoking
cessation, (2) LDL-c less than 100 mg/dL, (3) BP lower than 140/90 mmHg, and (4) HbA1c less
than 7%. Exacerbation of a CRF was defined as a 10% or more increase in BP, LDL-c, or HbA1c,
with respect to initial levels. Secondary outcomes were: the proportion of patients achieving
the treatment goal in each of the outcome measurements, quantitative changes in LDL-c, BP,
BMI, and HbA1c (in diabetic patients), and changes in quality of life and level of anxiety.
– Results. Four patients were lost in the followup (1.9%) and 5 died (2.5%), all in the CG.
Seventeen patients left the study (8.4%), 12 in the TmG (11.8%) and 5 in the CG (4.9%) (RR =
2.38; 95% CI = 0.87-6.50; P =.08). Reasons for leaving the program in the TmG were stress
associated with the use of the telemonitoring equipment in 3 patients, personal reasons in 7,
and inability to handle the equipment in 2 patients; in the CG, all 5 attributed it to personal
reasons.
Analysis on the basis of intention to treat showed that patients in the TmG were more likely
(RR = 1.4; 95% CI = 1.1-1.7) to experience improvement in their CRF profile than patients in the
CG (P =.010) at the end of 12 months. More TmG patients achieved the treatment goal in BP
(62.1% vs 42.9%, P =.012; RR =1.4, 95% CI = 1.1-1.9) and in HbA1c among diabetic patients
(86.4% vs 54.2%, P =.018; RR = 1.6; 95% CI = 1.1-2.4); there were no between-group differences
for smoking cessation (80.7% vs 81.0%, P =.964; RR = 1.0; 95% CI = 0.9-1.1) or LDL-c (76.2% vs
76.6%, P =.948; RR = 1.0; 95% CI = 0.9-1.2).
Quantitative changes in continuous variables with comparison of the difference between the
groups: Patients in the TmG showed significant changes in all variables with the exception of
diastolic BP (DBP) (systolic BP [SBP], P =.0460; DBP, P =.237; LDL-c, P =.027; HbA1c, P =.001;
BMI in overweight patients P =.003). In the CG, significant reductions were obtained in LDL-
c and DBP (SBP, P =.780; DBP, P =.001; LDL-c, P =.098; HbA1c, P =.239; BMI, P =.299). Body
mass index diminished in the TmG and increased slightly in the CG. Triglyceride levels also
decreased significantly in the TmG (P =.0001), but not in the CG (P =.435). No differences
between-groups were found in physical activity (75% TmG vs 73% CG, P =.756) or medication
adherence (99% in both groups, P =.980) both self-reported by patients. Nutritional habits were
not explored. There were no significant differences between the scores obtained in SF-36 and
State-Trait Anxiety Inventory tests at the initial visit in the 2 groups and changes were not
significant between groups. At 12 months, the SF-36 “physical health” scale showed a 2.8-point
increase in the TmG (P =.011) and a 1.5-point increase in the CG (P =.16). The change was smaller
in the “mental health” scale, with a 0.5-point increase in the TMG (P =.64) and a 0.5-point
decrease (P =.73) in the CG.
(B) Protocol acceptability: Adherence to protocol was measured by the percentage of WAP
sessions held (89.2% ± 16.0). Almost all patients (98%) completed more than 50% of WAP
sessions and more than 83% completed more than 75% of them. Only 0.5 messages per patient
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were missed, due to the mobile phone being turned off. Family support of the TmG patients
was analyzed at 4 different levels: never (58% of patients), first week only (10%), 1 month (7%),
and always (25%).
– Comments. A telemonitoring program, via mobile phone messages, appears to be useful for
improving the risk profile in ACS survivors and can be an effective tool for secondary
prevention, especially for overweight patients.
Other already carried out and finished projects are described briefly below
• Control and monitoring of self-care plans in asthma by means of a telemedicine platform.
(FIS 02/1391. SEP 1201/02. AIRMED II Program). [57].
– Main objective. To evaluate the efficacy of a monitoring and self-care program for asthmatic
patients based on telemedicine services. Secondary objectives: To evaluate the efficacy of the
program as regards the adhesion to the self-care plans and to the adhesion to the monitoring
of the FEM and FEV1. To evaluate the efficacy of the program as regards the clinical evolution
of the asthma and quality of life of the patients with asthma.
– Type of study. Quasi-experimental project with two differentiated groups: study and control.
37 patients of the Pneumology Unit of the Hospital Universitario Puerta de Hierro, Madrid,
Spain. October 2004 –May 2007. Intervention period, 12 months.
– Description intervention. All of the patients have their FEM and FEV1 monitored daily
(morning and evening) (volume expired in the first second), by means of a portable spirometer,
their symptoms and the medication taken. Those of the CG entered their data manually on ad-
hoc designed forms and acted in accordance with the guidelines given during the consultation.
The patients of the TmG followed the same medical protocol, although unlike the control
group, they had the permanent support of the telemedicine platform which sent the protocol
information by means of a mobile telephone (spirometry through CSD-GSM transmission, and
symptoms and actions by means of a WAP session on GPRS-GSM). The patients of the TmG
immediately and automatically received an SMS message as a reply which included informa‐
tion on their current state and the recommended medication guidelines in accordance with
their personalized plan. The doctor also has permanent access to the information sent and
evolution of each TmG patient so that he or she could individually supervise the development
of the self-care plans.
– Results. There we no significant differences as regards the monitoring of the FEV1 at home
and in the consultations of the study group. Compliance with the self-care plans was 70% in
more than half of the patients. Adherence to the self-treatment plans was greater in the study
group (95.28%) than in the control (93.09%).
– Comments. The tool that was designed to help in the decision-making process was highly
evaluated by both the patients and professionals.
• AmIVital. Digital personal environment for health and wellbeing. (CENIT2007-1010). [58].
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Within the (2008-2011) framework of a great technological project in which companies such as
Siemens, Telefónica, Ericsson and Telvent have participated, together with 4 SMEs and 8
Universities and Public research Centers, our group has carried out the following studies:
– Study of the prevalence and co-morbidity of heart failure in the family practice. [59].
– Type of study. A cross-sectional, observational descriptive study set in a health area of the
Community of Madrid, Spain. The study was carried out in a population of 198 670 individuals
over 14 years of age, attended to by 129 specialists in family medicine. The patient was
considered to have HF when this diagnosis (ICPC code K77) appeared in his or her electronic
medical record. The prevalence of HF was quantified and its association with another 25
chronic diseases was analyzed.
– Results. The prevalence of HF was 6.9%, 7.9% among women and 5.9% among men. Patients
with HF had a high rate of chronic co-morbidity, with an average of 5.2 + 2.1 chronic diseases.
Only 3% of the patients present with isolated HF and >60% have four or more additional
chronic problems. Hypertension, cardiac arrhythmias, hyperlipidaemia, obesity and diabetes
mellitus are the chronic diseases most frequently detected in HF patients.
– Comments. Patients with HF frequently visit the offices of family physicians, presenting with
a high rate of cardiac and non-cardiac co-morbidity that proves to be a challenge on the clinical
level and in terms of the organization of health care services.
– Study of disability measured by WHO-DAS II. [60].
– Type of study. Samples of consecutive patients diagnosed with COPD (102), CHF (99), and
stroke (99) were taken from 1,053 primary care users in the southern area of the autonomous
region of Madrid. The patients were informed of the study and were assessed in their homes
by trained field workers using the World Health Organization Disability Assessment Schedule
II (WHO-DAS II).
– Results. None of the groups had extreme disability on their overall WHO-DAS II scores. The
prevalence of severe disability differed among the groups and was highest for stroke and CHF
(33.33% and 29.29%, respectively) and lowest for COPD (14.71%). The three groups shared two
similar traits, namely, a higher prevalence of disability among women than men, and a specific
pattern by domain, with the highest prevalence of severe/extreme limitations being found in
household life activities and mobility. Severe restrictions in Social Participation were more
frequent in patients with stroke and CHF. The group with moderate disability according to
the overall WHODAS II score (n=94) showed a high prevalence of severe limitations in
mobility, life activities and self-care.
– Comments. Disability among non-institutionalized persons with COPD, CHF and stroke is
frequent and shows gender- and domain-related patterns similar to those described in a
population-based study performed using the WHO-DAS II in elderly persons in Spain. ICF-
validated disability categories could be useful in epidemiological surveys, individual assess‐
ments and primary care data monitoring systems.
– Co-morbidity Patterns in Patients with Chronic Diseases in General Practice. [61].
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– Type of study. A cross-sectional study was conducted in a health-area setting of the Madrid
Autonomous Region, covering a population of 198,670 individuals aged over 14 years old.
Multiple correspondences were analyzed to identify the clustering patterns of the conditions
targeted.
– Results. Forty-two percent (95% confidence interval [CI]: 41.8–42.2) of the registered
population had at least one chronic condition. In all, 24.5% (95% CI: 24.3–24.6) of the population
presented with multi-morbidity. In the correspondence analysis, 98.3% of the total information
was accounted for by three dimensions. The following four, age- and sex-related co-morbidity
patterns were identified: pattern B, showing a high co-morbidity rate; pattern C, showing a
low co-morbidity rate; and two patterns, A and D, showing intermediate co-morbidity rates.
– Comments. Four co-morbidity patterns could be identified which grouped diseases as
follows: one showing diseases with a high co-morbidity burden; one showing diseases with a
low co-morbidity burden; and two showing diseases with an intermediate co-morbidity
burden.
4.2. Current projects
4.2.1. Our own projects
Current projects as envisaged projects of our group are described briefly below.
• Monitoring of the elderly in assisted spaces for independent living. [FIS PI08-0435]
– Main objective. : To study how the monitoring of domestic activities may help to achieve a
better overall geriatric evaluation and better attention to the elderly in their homes.
– Type of study. Pilot study with 30 patients at a geriatric unit at the Hospital Universitario
Ramón y Cajal, Madrid, Spain. Commencement: February 2010.
– Intervention description. Two information methods were used: one subjective, by means of
an integrated evaluation scale: Barthel, Lawton-Brody, Mini-Nutritional, Mini-Mental State
Exam, Geriatric Depression Scale, Morisky-Green and Short Physical Performance Battery).
Another objective: by means of an environmental monitoring. The following was installed in
the homes of each patient: 5 presence detectors, 2 magnetic door opening sensors (refrigerator
and front door), 2 pressure sensors (bed and armchair), 1 sensor in their pill box, 1 for the use
of the telephone, for a week-10 days to obtain basic values for the behavior pattern.
– Study variables. 15 items were analyzed related to: Therapeutic Control, In-house Mobility,
Outdoor Mobility, Personal Hygiene, Cleanliness: Urination/Bowel movements, Dressing,
Domestic activities, Emotional, Memory, Orientation, Meals, Personal, Telephone use.
– Comments. Finalization 1st phase envisaged December 2012.
– Monitoring of an advanced Spanish EPOC cohort (CEPA). [FIS PS09-01787].
– Main objective. Describe the clinical course of the EPOC in terms of clinical data, functional
and radiological. Secondary objectives: Describe the incident mortality and causes of death.
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Describe the phenotypic features and group them together in their respective dimensions or
factors. Describe the assorted and incident morbidity. Describe the health care load on the
health system (use of medication and frequency of doctor and hospitals consultations). Explore
the viability of the application of the weekly questionnaires.
– Type of study. Observational study, longitudinal and concurrent of two groups of patients
with advanced EPOC. 214 patients were enrolled by 32 pneumologists and followed by 32
nurses from 32 hospitals from all of the regions, Spain. Commenced November 2011. Inter‐
vention period: 18 months.
– Intervention description. In both groups: Programmed weekly visits to pneumonological
services of the corresponding hospital. The TmG patients will answer a weekly questionnaire
from home of 12 questions related to their state of health. They can choose the internet, mobile
telephone or interactive voice by means of a fixed or mobile telephone (IVR) to fill in and send
their weekly questionnaire.
– Study variables. In the weekly visits of both groups: personal and demographic data, health
model, diagnostics, risk factors, symptoms, signs, current treatment, use of resources, quality
of life (CAT), anxiety/depression (HAD), as well as tests to determine biochemical and blood
count, pulmonary function, blood-gas analysis, BODE, blood, TAC, echocardiogram. In the
weekly questionnaire: a) degree of breathlessness, b) fever, c) expectoration, d) nocturnal
symptoms, e) treatment, f) level of activity, g) tobacco, and h) use of health resources.
– Comments. Finalization envisaged in October 2013.
• REHABILITA. Disruptive technologies for future rehabilitation. [CENIT2009-1043]. [62]
Support the interoperability in the development of the project by means of the use of medical
report services and archetypes of the PITES platform. The medical report services and
archetypes are used as a support for the sending and consulting of information from the
monitoring devices of the patients during the development of the REHABILITA services
platform.
Semantically interoperable interconnection of the servers of the REHABILITA platform with
the information systems of the health centers involved. The PITES platform is being used as
an information and archetypes buffer for the reading of the information of the systems of the
health organizations (acquisition of data for the preparation of therapeutic explanations) and
for the storage of the results of the rehabilitation sessions in the electronic clinical records
storage systems.
Development in the PITES platform of an observatory of disruptive technologies in rehabili‐
tation as a collaboration Web space of the researchers of the project; by means of its analysis
and study; then applying it in the aspects of use for innovation activities in the said domain.
– Comments. Finalization envisaged April 2013.
• PITES-ISA. Innovation platform in new telemedicine and e-health services: Definition,
design and development of tools for interoperability, patient safety and help in decision
making. [FIS PI12-00508.]
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– Main objective. Updating of the PITES platform through the creation of an environment for
the development of technological support of new devices for biomedical, contextual and
environmental monitoring, and new applications and services based on Internet and Internet
devices. The inclusion of new archetypes and knowledge management server and a new
medical report and information management server. Development of: a) new client applica‐
tions for access to both servers, b) safety policy in accordance with ISO EN 13606, and c)
applications for advanced visualization.
– Comments. Commencement envisaged January 2013.
4.2.2. Projects of other groups
In 2009 the possibility opened up for the PITES platform to be used by other research groups
within the Spanish National Health Service. Without describing them for reasons of confiden‐
tiality, current projects and envisaged projects are cited below.
• Current projects, which are envisaged to finish throughout 2013.
• Monitoring and control based on telemedicine patients with (TAO-E) oral anticoagulation
treatment. [FIS PI09-90094]. Bioengineering and Telemedicine Unit. Hospital Universitario
Puerta de Hierro. Majadahonda. Madrid.
• Methods and tools for the design and implementation of telemedicine and e-health services
for the attention of chronic patients. [FIS PI09-90518]. Hospital Universitario Virgen del
Rocío. Sevilla. Andalucía.
• Integral attention to aged chronic-dependent people. Evaluation of the interlinked provision
of health and social services - (AYUDA). [FIS PI09-90549]. Barbastro Health Sector. Huesca.
Aragón.
• Hospitalization at home and rare illnesses in Navarra. Evaluation of the home health care
and identification of added-value e-health services. [FIS PI09-90317]. Medical-Technological
Complex of Navarra. Pamplona. Navarra.
• Innovative health care services integrated for chronic patients. [FIS PI09-90634]. Hospital
Clinic. Barcelona. Cataluña.
• Effectiveness of a telemedicine program in the monitoring and control de patients con
metabolic syndrome within the ambit of primary attention. [FIS PI09/90285]. Management
of Primary Attention. Albacete. Castilla la Mancha.
• Approved projects, envisaged to begin throughout 2013.
• T-CUIDAENCASA: Innovation platform at home telemedicine services. [FIS PI12/00673].
Barbastro Health Sector. Huesca. Aragón
• Regional scalability of the integrated attention services and aid in the clinical decision. [FIS
PI12-01241]. Hospital Clínic de Barcelona. Cataluña.
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• Implementation of tools to aid in the decision, interoperability and safety for an e-service
for the early detection of exacerbations in EPOC patients "frequent-user phenotype ". [FIS
PI12/01305]. Hospital Universitario Puerta de Hierro. Majadahonda. Madrid.
• Development de a system of at home attention for rheumatologic patients. [FIS PI2-01415].
Hospitalario Universitario Complex A Coruña. Galicia.
• PREVICA MULTICANAL. Contribution of telemedicine to the health care continuity of the
complex chronic patient. [FIS PI12-01433]. Hospital Universitario Marqués de Valdecilla.
Santander. Cantabria.
• Definition, design and development of tools and services based on standards for the support
of the clinical decision and personalized medicine. [FIS PI12-01571]. Hospital Universitario
Virgen del Rocío. Sevilla. Andalucía.
5. Conclusion
This chapter shows how an infrastructure composed of an open systems technological
platform and an interdisciplinary team of technologist researchers and health and social
sciences specialists aimed at research groups and public and private organizations and entities
as described in the Description section can support simultaneous telemedicine-based services
deployment in order to obtain evidence through the execution of experimental studies in
chronicity and associated disabilities-related healthcare provision scenarios such as those
presented in the Results section.
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